1,117 results on '"K. Yue"'
Search Results
2. First measurement of isoscalar giant resonances in a stored-beam experiment
- Author
-
J.C. Zamora, T. Aumann, S. Bagchi, S. Bönig, M. Csatlós, I. Dillmann, C. Dimopoulou, P. Egelhof, V. Eremin, T. Furuno, H. Geissel, R. Gernhäuser, M.N. Harakeh, A.-L. Hartig, S. Ilieva, N. Kalantar-Nayestanaki, O. Kiselev, H. Kollmus, C. Kozhuharov, A. Krasznahorkay, Th. Kröll, M. Kuilman, S. Litvinov, Yu.A. Litvinov, M. Mahjour-Shafiei, M. Mutterer, D. Nagae, M.A. Najafi, C. Nociforo, F. Nolden, U. Popp, C. Rigollet, S. Roy, C. Scheidenberger, M. von Schmid, M. Steck, B. Streicher, L. Stuhl, M. Thürauf, T. Uesaka, H. Weick, J.S. Winfield, D. Winters, P.J. Woods, T. Yamaguchi, K. Yue, and J. Zenihiro
- Subjects
Physics ,QC1-999 - Abstract
A new technique developed for measuring nuclear reactions at low momentum transfer with stored beams in inverse kinematics was successfully used to study isoscalar giant resonances. The experiment was carried out at the experimental heavy-ion storage ring (ESR) at the GSI facility using a stored 58Ni beam at 100 MeV/u and an internal helium gas-jet target. In these measurements, inelastically scattered α-recoils at very forward center-of-mass angles (θcm≤1.5°) were detected with a dedicated setup, including ultra-high vacuum compatible detectors. Experimental results indicate a dominant contribution of the isoscalar giant monopole resonance at this very forward angular range. It was found that the monopole contribution exhausts 79−11+12% of the energy-weighted sum rule (EWSR), which agrees with measurements performed in normal kinematics. This opens up the opportunity to investigate the giant resonances in a large domain of unstable and exotic nuclei in the near future. It is a fundamental milestone towards new nuclear reaction studies with stored ion beams. Keywords: Storage ring, Inverse kinematics, Isoscalar giant resonances
- Published
- 2016
- Full Text
- View/download PDF
3. Clinical profile of patients with acute traumatic brain injury undergoing cranial surgery in the United States: report from the 18-centre TRACK-TBI cohort studyResearch in context
- Author
-
John K. Yue, John H. Kanter, Jason K. Barber, Michael C. Huang, Thomas A. van Essen, Mahmoud M. Elguindy, Brandon Foreman, Frederick K. Korley, Patrick J. Belton, Dana Pisică, Young M. Lee, Ryan S. Kitagawa, Mary J. Vassar, Xiaoying Sun, Gabriela G. Satris, Justin C. Wong, Adam R. Ferguson, J. Russell Huie, Kevin K.W. Wang, Hansen Deng, Vincent Y. Wang, Yelena G. Bodien, Sabrina R. Taylor, Debbie Y. Madhok, Michael A. McCrea, Laura B. Ngwenya, Anthony M. DiGiorgio, Phiroz E. Tarapore, Murray B. Stein, Ava M. Puccio, Joseph T. Giacino, Ramon Diaz-Arrastia, Hester F. Lingsma, Pratik Mukherjee, Esther L. Yuh, Claudia S. Robertson, David K. Menon, Andrew I.R. Maas, Amy J. Markowitz, Sonia Jain, David O. Okonkwo, Nancy R. Temkin, Geoffrey T. Manley, Jason E. Chung, Bukre Coskun, Shawn R. Eagle, Leila L. Etemad, Brian Fabian, Feeser V. Ramana, Shankar Gopinath, Christine J. Gotthardt, Ramesh Grandhi, Sabah Hamidi, Ruchira M. Jha, Christopher Madden, Randall Merchant, Lindsay D. Nelson, Richard B. Rodgers, Andrea L.C. Schneider, David M. Schnyer, Abel Torres-Espin, Joye X. Tracey, Alex B. Valadka, and Ross D. Zafonte
- Subjects
Decompressive craniectomy ,Craniotomy ,Glasgow outcome scale ,Medical decisionmaking ,Neuroimaging ,Triage ,Public aspects of medicine ,RA1-1270 - Abstract
Summary: Background: Contemporary surgical practices for traumatic brain injury (TBI) remain unclear. We describe the clinical profile of an 18-centre US TBI cohort with cranial surgery. Methods: The prospective, observational Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study (2014–2018; ClinicalTrials.gov #NCT02119182) enrolled subjects who presented to trauma centre and received head computed tomography within 24-h (h) post-TBI. We performed a secondary data analysis in subjects aged ≥17-years with hospitalisation. Clinical characteristics, surgery type/timing, hospital and six-month outcomes were reported. Findings: Of 2032 subjects (age: mean = 41.4-years, range = 17–89-years; male = 71% female = 29%), 260 underwent cranial surgery, comprising 65% decompressive craniectomy, 23% craniotomy, 12% other surgery. Subjects with surgery (vs. without surgery) presented with worse neurological injury (median Glasgow Coma Scale = 6 vs. 15; midline shift ≥5 mm: 48% vs. 2%; cisternal effacement: 61% vs. 4%; p
- Published
- 2024
- Full Text
- View/download PDF
4. Parsimonious immune-response endotypes and global outcome in patients with traumatic brain injuryResearch in context
- Author
-
Romit J. Samanta, Anne-Cécile Chiollaz, Edward Needham, John K. Yue, Adel Helmy, Elisa R. Zanier, Kevin K.W. Wang, Firas Kobeissy, Jussi P. Posti, Charlotte Summers, Geoffrey T. Manley, Andrew IR. Maas, Olli Tenovuo, Jean-Charles Sanchez, David K. Menon, Neeraj Badjatia, Ramon Diaz-Arrastia, Ann-Christine Duhaime, V Ramana Feeser, Shankar Gopinath, Ramesh Grandhi, Ruchira J. Ha, Dirk Keene, Christopher Madden, Michael McCrea, Randall Merchant, Laura B. Ngwenya, Richard B. Rodgers, David Schnyer, Sabrina R. Taylor, Ross Zafonte, Cecilia Ackerlund, Krisztina Amrein, Nada Andelic, Lasse Andreassen, Audny Anke, Gérard Audibert, Philippe Azouvi, Maria Luisa Azzolini, Ronald Bartels, Ronny Beer, Bo-Michael Bellander, Habib Benali, Maurizio Berardino, Luigi Beretta, Erta Beqiri, Morten Blaabjerg, Stine Borgen Lund, Camilla Brorsson, Andras Buki, Manuel Cabeleira, Alessio Caccioppola, Emiliana Calappi, Maria Rosa Calvi, Peter Cameron, Guillermo Carbayo Lozano, Marco Carbonara, Ana M. Castaño-León, Simona Cavallo, Giorgio Chevallard, Arturo Chieregato, Giuseppe Citerio, Hans Clusmann, Mark Steven Coburn, Jonathan Coles, Jamie D. Cooper, Marta Correia, Endre Czeiter, Marek Czosnyka, Claire Dahyot-Fizelier, Paul Dark, Véronique De Keyser, Vincent Degos, Francesco Della Corte, Hugo den Boogert, Bart Depreitere, Đula Đilvesi, Abhishek Dixit, Jens Dreier, Guy-Loup Dulière, Ari Ercole, Erzsébet Ezer, Martin Fabricius, Kelly Foks, Shirin Frisvold, Alex Furmanov, Damien Galanaud, Dashiell Gantner, Alexandre Ghuysen, Lelde Giga, Jagoš Golubović, Pedro A. Gomez, Benjamin Gravesteijn, Francesca Grossi, Deepak Gupta, Iain Haitsma, Raimund Helbok, Eirik Helseth, Jilske Huijben, Peter J. Hutchinson, Stefan Jankowski, Faye Johnson, Mladen Karan, Angelos G. Kolias, Daniel Kondziella, Evgenios Kornaropoulos, Lars-Owe Koskinen, Noémi Kovács, Ana Kowark, Alfonso Lagares, Steven Laureys, Fiona Lecky, Didier Ledoux, Roger Lightfoot, Hester Lingsma, Andrew I.R. Maas, Alex Manara, Hugues Maréchal, Costanza Martino, Julia Mattern, Catherine McMahon, David Menon, Tomas Menovsky, Benoit Misset, Visakh Muraleedharan, Lynnette Murray, Ancuta Negru, David Nelson, Virginia Newcombe, József Nyirádi, Fabrizio Ortolano, Jean-François Payen, Vincent Perlbarg, Paolo Persona, Wilco Peul, Anna Piippo-Karjalainen, Horia Ples, Inigo Pomposo, Louis Puybasset, Andreea Rădoi, Arminas Ragauskas, Rahul Raj, Jonathan Rhodes, Sophie Richter, Saulius Rocka, Cecilie Roe, Olav Roise, Jeffrey Rosenfeld, Christina Rosenlund, Guy Rosenthal, Rolf Rossaint, Sandra Rossi, Juan Sahuquillo, Oliver Sakowitz, Renan Sanchez-Porras, Oddrun Sandrød, Kari Schirmer-Mikalsen, Rico Frederik Schou, Charlie Sewalt, Peter Smielewski, Abayomi Sorinola, Emmanuel Stamatakis, Ewout W. Steyerberg, Nino Stocchetti, Nina Sundström, Riikka Takala, Viktória Tamás, Tomas Tamosuitis, Matt Thomas, Dick Tibboel, Christos Tolias, Tony Trapani, Cristina Maria Tudora, Andreas Unterberg, Peter Vajkoczy, Egils Valeinis, Shirley Vallance, Zoltán Vámos, Gregory Van der Steen, Jeroen T.J.M. van Dijck, Thomas A. van Essen, Roel van Wijk, Alessia Vargiolu, Emmanuel Vega, Anne Vik, Rimantas Vilcinis, Victor Volovici, Peter Vulekovic, Eveline Wiegers, Guy Williams, Stefan Winzeck, Stefan Wolf, Alexander Younsi, Frederick A. Zeiler, Agate Ziverte, and Tommaso Zoerle
- Subjects
Traumatic brain injury ,Stratified medicine ,Inflammation ,Clustering ,Medicine ,Medicine (General) ,R5-920 - Abstract
Summary: Background: The inflammatory response in patients with traumatic brain injury (TBI) offers opportunities for stratification and intervention. Previous unselected approaches to immunomodulation in patients with TBI have not improved patient outcomes. Methods: Serum and plasma samples from two prospective, multi-centre observational studies of patients with TBI were used to discover (Collaborative European NeuroTrauma Effectiveness Research [CENTER-TBI], Europe) and validate (Transforming Research and Clinical Knowledge in Traumatic Brain Injury [TRACK-TBI] Pilot, USA) individual variations in the immune response using a multiplex panel of 30 inflammatory mediators. Mediators that were associated with unfavourable outcomes (Glasgow outcome score-extended [GOS-E] ≤ 4) were used for hierarchical clustering to identify patients with similar signatures. Findings: Two clusters were identified in both the discovery and validation cohorts, termed early-inflammatory and pauci-inflammatory. The early-inflammatory phenotype had higher concentrations of interleukin-6 (IL-6), IL-15, and monocyte chemoattractant protein 1 (MCP1). Patients with the early-inflammatory phenotype were older and more likely to have an unfavourable GOS-E at 6 months. There were no differences in the baseline injury severity scores between patients in each phenotype. A combined IL-15 and MCP1 signature identified patients with the early-inflammatory phenotype in both cohorts. Inflammatory processes mediated outcomes in older patients with moderate-severe TBI. Interpretation: Our findings offer a precision medicine approach for future clinical trials of immunomodulation in patients with TBI, by using inflammatory signatures to stratify patients. Funding: CENTER-TBI study was supported by the European Union 7th Framework Programme. TRACK-TBI is supported by the National Institute of Neurological Disorders and Stroke.
- Published
- 2024
- Full Text
- View/download PDF
5. Prior traumatic brain injury is a risk factor for in-hospital mortality in moderate to severe traumatic brain injury: a TRACK-TBI cohort study
- Author
-
Hester F Lingsma, Ramesh Grandhi, Amy J Markowitz, Debbie Y Madhok, Geoffrey T Manley, Jason Barber, Xiaoying Sun, Michael A McCrea, Kevin K W Wang, Lindsay D Nelson, Pratik Mukherjee, Neeraj Badjatia, Ava M Puccio, David O Okonkwo, Patrick J Belton, Sonia Jain, Nancy R Temkin, Cathra Halabi, Richard B Rodgers, Andrea L C Schneider, Shawn R Eagle, Shankar Gopinath, Randall Merchant, Ross D Zafonte, Raquel C Gardner, John K Yue, Leila L Etemad, Mahmoud M Elguindy, Thomas A van Essen, Rick J G Vreeburg, Christine J Gotthardt, Joye X Tracey, Bukre C Coskun, Nishanth Krishnan, Frederick K Korley, Claudia S Robertson, Ann-Christine Duhaime, Gabriela G Satris, Phiroz E Tarapore, Michael C Huang, Joseph T Giacino, Esther L Yuh, Alex B Valadka, Anthony M DiGiorgio, Yelena G Bodien, Brian Fabian, Adam R Ferguson, Brandon Foreman, J Russell Huie, C Dirk Keene, Christine L MacDonald, Laura B Ngwenya, David M Schnyer, Sabrina R Taylor, Abel Torres-Espin, Mary J Vassar, and Justin C Wong
- Subjects
Surgery ,RD1-811 ,Medical emergencies. Critical care. Intensive care. First aid ,RC86-88.9 - Abstract
Objectives An estimated 14–23% of patients with traumatic brain injury (TBI) incur multiple lifetime TBIs. The relationship between prior TBI and outcomes in patients with moderate to severe TBI (msTBI) is not well delineated. We examined the associations between prior TBI, in-hospital mortality, and outcomes up to 12 months after injury in a prospective US msTBI cohort.Methods Data from hospitalized subjects with Glasgow Coma Scale score of 3–12 were extracted from the Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study (enrollment period: 2014–2019). Prior TBI with amnesia or alteration of consciousness was assessed using the Ohio State University TBI Identification Method. Competing risk regressions adjusting for age, sex, psychiatric history, cranial injury and extracranial injury severity examined the associations between prior TBI and in-hospital mortality, with hospital discharged alive as the competing risk. Adjusted HRs (aHR (95% CI)) were reported. Multivariable logistic regressions assessed the associations between prior TBI, mortality, and unfavorable outcome (Glasgow Outcome Scale-Extended score 1–3 (vs. 4–8)) at 3, 6, and 12 months after injury.Results Of 405 acute msTBI subjects, 21.5% had prior TBI, which was associated with male sex (87.4% vs. 77.0%, p=0.037) and psychiatric history (34.5% vs. 20.7%, p=0.010). In-hospital mortality was 10.1% (prior TBI: 17.2%, no prior TBI: 8.2%, p=0.025). Competing risk regressions indicated that prior TBI was associated with likelihood of in-hospital mortality (aHR=2.06 (1.01–4.22)), but not with hospital discharged alive. Prior TBI was not associated with mortality or unfavorable outcomes at 3, 6, and 12 months.Conclusions After acute msTBI, prior TBI history is independently associated with in-hospital mortality but not with mortality or unfavorable outcomes within 12 months after injury. This selective association underscores the importance of collecting standardized prior TBI history data early after acute hospitalization to inform risk stratification. Prospective validation studies are needed.Level of evidence IV.Trial registration number NCT02119182.
- Published
- 2024
- Full Text
- View/download PDF
6. Data-driven distillation and precision prognosis in traumatic brain injury with interpretable machine learning
- Author
-
Andrew Tritt, John K. Yue, Adam R. Ferguson, Abel Torres Espin, Lindsay D. Nelson, Esther L. Yuh, Amy J. Markowitz, Geoffrey T. Manley, Kristofer E. Bouchard, and the TRACK-TBI Investigators
- Subjects
Medicine ,Science - Abstract
Abstract Traumatic brain injury (TBI) affects how the brain functions in the short and long term. Resulting patient outcomes across physical, cognitive, and psychological domains are complex and often difficult to predict. Major challenges to developing personalized treatment for TBI include distilling large quantities of complex data and increasing the precision with which patient outcome prediction (prognoses) can be rendered. We developed and applied interpretable machine learning methods to TBI patient data. We show that complex data describing TBI patients' intake characteristics and outcome phenotypes can be distilled to smaller sets of clinically interpretable latent factors. We demonstrate that 19 clusters of TBI outcomes can be predicted from intake data, a ~ 6× improvement in precision over clinical standards. Finally, we show that 36% of the outcome variance across patients can be predicted. These results demonstrate the importance of interpretable machine learning applied to deeply characterized patients for data-driven distillation and precision prognosis.
- Published
- 2023
- Full Text
- View/download PDF
7. Neuroinflammatory Biomarkers for Traumatic Brain Injury Diagnosis and Prognosis: A TRACK-TBI Pilot Study
- Author
-
John K. Yue, Firas H. Kobeissy, Sonia Jain, Xiaoying Sun, Ryan R.L. Phelps, Frederick K. Korley, Raquel C. Gardner, Adam R. Ferguson, J. Russell Huie, Andrea L.C. Schneider, Zhihui Yang, Haiyan Xu, Cillian E. Lynch, Hansen Deng, Miri Rabinowitz, Mary J. Vassar, Sabrina R. Taylor, Pratik Mukherjee, Esther L. Yuh, Amy J. Markowitz, Ava M. Puccio, David O. Okonkwo, Ramon Diaz-Arrastia, Geoffrey T. Manley, Kevin K.W. Wang, Collaboration group, Neeraj Badjatia, Brandon Foreman, Shankar Gopinath, Ramesh Grandhi, Ruchira M. Jha, Hester F. Lingsma, Christopher Madden, Debbie Y. Madhok, Michael A. McCrea, Randall Merchant, Lindsay D. Nelson, Laura B. Ngwenya, Claudia S. Robertson, Richard B. Rodgers, Gabriela G. Satris, David M. Schnyer, Alex B. Valadka, Thomas A. van Essen, and Ross Zafonte
- Subjects
acute phase reactant ,alarmin ,cytokine ,neuroinflammation ,prognosis ,traumatic brain injury ,Medical emergencies. Critical care. Intensive care. First aid ,RC86-88.9 - Abstract
The relationship between systemic inflammation and secondary injury in traumatic brain injury (TBI) is complex. We investigated associations between inflammatory markers and clinical confirmation of TBI diagnosis and prognosis. The prospective TRACK-TBI Pilot (Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot) study enrolled TBI patients triaged to head computed tomography (CT) and received blood draw within 24?h of injury. Healthy controls (HCs) and orthopedic controls (OCs) were included. Thirty-one inflammatory markers were analyzed from plasma. Area under the receiver operating characteristic curve (AUC) was used to evaluate discriminatory ability. AUC >0.7 was considered acceptable. Criteria included: TBI diagnosis (vs. OC/HC); moderate/severe vs. mild TBI (Glasgow Coma Scale; GCS); radiographic TBI (CT positive vs. CT negative); 3- and 6-month Glasgow Outcome Scale-Extended (GOSE) dichotomized to death/greater relative disability versus less relative disability (GOSE 1?4/5?8); and incomplete versus full recovery (GOSE
- Published
- 2023
- Full Text
- View/download PDF
8. Association of Early Beta-Blocker Exposure and Functional Outcomes in Critically Ill Patients With Moderate to Severe Traumatic Brain Injury: A Transforming Clinical Research and Knowledge in Traumatic Brain Injury Study
- Author
-
Margot Kelly-Hedrick, MBE, Sunny Yang Liu, BA, Nancy Temkin, PhD, Jason Barber, MS, Jordan Komisarow, MD, Geoffrey Manley, MD, PhD, Tetsu Ohnuma, MD, MPH, PhD, Katharine Colton, MD, Miriam M. Treggiari, MD, MPH, PhD, Eric E. Monson, PhD, Monica S. Vavilala, MD, Ramesh Grandhi, MD, MS, Daniel T. Laskowitz, MD, MHS, Joseph P. Mathew, MD, MHS, MBA, Adrian Hernandez, MD, MHS, Michael L. James, MD, Karthik Raghunathan, MD, MPH, Ben Goldstein, PhD, Amy J. Markowitz, JD, Vijay Krishnamoorthy, MD, MPH, PhD, the Transforming Clinical Research and Knowledge in Traumatic Brain Injury Investigators, Neeraj Badjatia, MD, Adam R. Ferguson, PhD, Brandon Foreman, MD, Michael McCrea, PhD, Randall Merchant, PhD, Laura B. Ngwenya, MD, PhD, David Okonkwo, MD, PhD, David Schnyer, PhD, John K. Yue, MD, and Ross Zafonte, DO
- Subjects
Medical emergencies. Critical care. Intensive care. First aid ,RC86-88.9 - Abstract
OBJECTIVES:. We aimed to 1) describe patterns of beta-blocker utilization among critically ill patients following moderate–severe traumatic brain injury (TBI) and 2) examine the association of early beta-blocker exposure with functional and clinical outcomes following injury. DESIGN:. Retrospective cohort study. SETTING:. ICUs at 18 level I, U.S. trauma centers in the Transforming Clinical Research and Knowledge in TBI (TRACK-TBI) study. PATIENTS:. Greater than or equal to 17 years enrolled in the TRACK-TBI study with moderate–severe TBI (Glasgow Coma Scale of
- Published
- 2023
- Full Text
- View/download PDF
9. Comparative effectiveness of decompressive craniectomy versus craniotomy for traumatic acute subdural hematoma (CENTER-TBI): an observational cohort studyResearch in context
- Author
-
Thomas A. van Essen, Inge A.M. van Erp, Hester F. Lingsma, Dana Pisică, John K. Yue, Ranjit D. Singh, Jeroen T.J.M. van Dijck, Victor Volovici, Alexander Younsi, Angelos Kolias, Lianne D. Peppel, Majanka Heijenbrok-Kal, Gerard M. Ribbers, David K. Menon, Peter J.A. Hutchinson, Geoffrey T. Manley, Bart Depreitere, Ewout W. Steyerberg, Andrew I.R. Maas, Godard C.W. de Ruiter, Wilco C. Peul, Cecilia Åkerlund, Krisztina Amrein, Nada Andelic, Lasse Andreassen, Audny Anke, Anna Antoni, Gérard Audibert, Philippe Azouvi, Maria Luisa Azzolini, Ronald Bartels, Pál Barzó, Romuald Beauvais, Ronny Beer, Bo-Michael Bellander, Antonio Belli, Habib Benali, Maurizio Berardino, Luigi Beretta, Morten Blaabjerg, Peter Bragge, Alexandra Brazinova, Vibeke Brinck, Joanne Brooker, Camilla Brorsson, Andras Buki, Monika Bullinger, Manuel Cabeleira, Alessio Caccioppola, Emiliana Calappi, Maria Rosa Calvi, Peter Cameron, Guillermo Carbayo Lozano, Marco Carbonara, Ana M. Castaño-León, Simona Cavallo, Giorgio Chevallard, Arturo Chieregato, Giuseppe Citerio, Hans Clusmann, Mark Steven Coburn, Jonathan Coles, Jamie D. Cooper, Marta Correia, Amra Čović, Nicola Curry, Endre Czeiter, Marek Czosnyka, Claire Dahyot-Fizelier, Paul Dark, Helen Dawes, Véronique De Keyser, Vincent Degos, Francesco Della Corte, Hugo den Boogert, Đula Đilvesi, Abhishek Dixit, Emma Donoghue, Jens Dreier, Guy-Loup Dulière, Ari Ercole, Patrick Esser, Erzsébet Ezer, Martin Fabricius, Valery L. Feigin, Kelly Foks, Shirin Frisvold, Alex Furmanov, Pablo Gagliardo, Damien Galanaud, Dashiell Gantner, Guoyi Gao, Pradeep George, Alexandre Ghuysen, Lelde Giga, Ben Glocker, Jagoš Golubović, Pedro A. Gomez, Johannes Gratz, Benjamin Gravesteijn, Francesca Grossi, Russell L. Gruen, Deepak Gupta, Juanita A. Haagsma, Iain Haitsma, Raimund Helbok, Eirik Helseth, Lindsay Horton, Jilske Huijben, Peter J. Hutchinson, Bram Jacobs, Stefan Jankowski, Mike Jarrett, Ji-yao Jiang, Faye Johnson, Kelly Jones, Mladen Karan, Angelos G. Kolias, Erwin Kompanje, Daniel Kondziella, Evgenios Kornaropoulos, Lars-Owe Koskinen, Noémi Kovács, Alfonso Lagares, Linda Lanyon, Steven Laureys, Fiona Lecky, Didier Ledoux, Rolf Lefering, Valerie Legrand, Aurelie Lejeune, Leon Levi, Roger Lightfoot, Hester Lingsma, Marc Maegele, Marek Majdan, Alex Manara, Geoffrey Manley, Hugues Maréchal, Costanza Martino, Julia Mattern, Catherine McMahon, Béla Melegh, David Menon, Tomas Menovsky, Ana Mikolic, Benoit Misset, Visakh Muraleedharan, Lynnette Murray, Nandesh Nair, Ancuta Negru, David Nelson, Virginia Newcombe, Daan Nieboer, József Nyirádi, Matej Oresic, Fabrizio Ortolano, Olubukola Otesile, Aarno Palotie, Paul M. Parizel, Jean-François Payen, Natascha Perera, Vincent Perlbarg, Paolo Persona, Wilco Peul, Anna Piippo-Karjalainen, Matti Pirinen, Dana Pisica, Horia Ples, Suzanne Polinder, Inigo Pomposo, Jussi P. Posti, Louis Puybasset, Andreea Rădoi, Arminas Ragauskas, Rahul Raj, Malinka Rambadagalla, Veronika Rehorčíková, Isabel Retel Helmrich, Jonathan Rhodes, Sylvia Richardson, Sophie Richter, Samuli Ripatti, Saulius Rocka, Cecilie Roe, Olav Roise, Jonathan Rosand, Jeffrey Rosenfeld, Christina Rosenlund, Guy Rosenthal, Rolf Rossaint, Sandra Rossi, Daniel Rueckert, Martin Rusnák, Juan Sahuquillo, Oliver Sakowitz, Renan Sanchez-Porras, Janos Sandor, Nadine Schäfer, Silke Schmidt, Herbert Schoechl, Guus Schoonman, Rico Frederik Schou, Elisabeth Schwendenwein, Charlie Sewalt, Toril Skandsen, Peter Smielewski, Abayomi Sorinola, Emmanuel Stamatakis, Simon Stanworth, Ana Kowark, Robert Stevens, William Stewart, Nino Stocchetti, Nina Sundström, Riikka Takala, Viktória Tamás, Tomas Tamosuitis, Mark Steven Taylor, Braden Te Ao, Olli Tenovuo, Alice Theadom, Matt Thomas, Dick Tibboel, Marjolijn Timmers, Christos Tolias, Tony Trapani, Cristina Maria Tudora, Andreas Unterberg, Peter Vajkoczy, Egils Valeinis, Shirley Vallance, Zoltán Vámos, Mathieu Van der Jagt, Joukje van der Naalt, Gregory Van der Steen, Wim Van Hecke, Caroline van Heugten, Dominique Van Praag, Ernest Van Veen, Roel van Wijk, Thijs Vande Vyvere, Alessia Vargiolu, Emmanuel Vega, Kimberley Velt, Jan Verheyden, Paul M. Vespa, Anne Vik, Rimantas Vilcinis, Nicole von Steinbüchel, Daphne Voormolen, Petar Vulekovic, Kevin K.W. Wang, Eveline Wiegers, Guy Williams, Lindsay Wilson, Stefan Winzeck, Stefan Wolf, Zhihui Yang, Peter Ylén, Frederick A. Zeiler, Agate Ziverte, and Tommaso Zoerle
- Subjects
Acute subdural hematoma ,Decompressive craniectomy ,Craniotomy ,Comparative effectiveness research ,Instrumental variable analysis ,Practice variation ,Medicine (General) ,R5-920 - Abstract
Summary: Background: Limited evidence existed on the comparative effectiveness of decompressive craniectomy (DC) versus craniotomy for evacuation of traumatic acute subdural hematoma (ASDH) until the recently published randomised clinical trial RESCUE-ASDH. In this study, that ran concurrently, we aimed to determine current practice patterns and compare outcomes of primary DC versus craniotomy. Methods: We conducted an analysis of centre treatment preference within the prospective, multicentre, observational Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (known as CENTER-TBI) and NeuroTraumatology Quality Registry (known as Net-QuRe) studies, which enrolled patients throughout Europe and Israel (2014–2020). We included patients with an ASDH who underwent acute neurosurgical evacuation. Patients with severe pre-existing neurological disorders were excluded. In an instrumental variable analysis, we compared outcomes between centres according to treatment preference, measured by the case-mix adjusted proportion DC per centre. The primary outcome was functional outcome rated by the 6-months Glasgow Outcome Scale Extended, estimated with ordinal regression as a common odds ratio (OR), adjusted for prespecified confounders. Variation in centre preference was quantified with the median odds ratio (MOR). CENTER-TBI is registered with ClinicalTrials.gov, number NCT02210221, and the Resource Identification Portal (Research Resource Identifier SCR_015582). Findings: Between December 19, 2014 and December 17, 2017, 4559 patients with traumatic brain injury were enrolled in CENTER-TBI of whom 336 (7%) underwent acute surgery for ASDH evacuation; 91 (27%) underwent DC and 245 (63%) craniotomy. The proportion primary DC within total acute surgery cases ranged from 6 to 67% with an interquartile range (IQR) of 12–26% among 46 centres; the odds of receiving a DC for prognostically similar patients in one centre versus another randomly selected centre were trebled (adjusted median odds ratio 2.7, p
- Published
- 2023
- Full Text
- View/download PDF
10. Diagnostic performance of point-of-care ubiquitin carboxy-terminal Hydrolase-L1 assay in distinguishing imaging abnormalities in traumatic brain injury: A TRACK-TBI cohort study
- Author
-
Kevin K. Wang, Jennifer C. Munoz-Pareja, Lauren A. Lautenslager, J. Adrian Tyndall, Zhihui Yang, Maria R. Kerrigan, Ramon Diaz-Arrastia, Frederick K. Korley, David Okonkwo, Ava M. Puccio, John K. Yue, Sabrina R. Taylor, Pratik Mukherjee, Esther L. Yuh, Nancy R. Temkin, Claudia S. Robertson, Xiaoying Sun, Sonia Jain, Amy J. Markowitz, Geoffrey T. Manley, Opeolu Adeoye, Neeraj Badjatia, Kim Boase, Yelena Bodien, M. Ross Bullock, Randall Chesnut, John D. Corrigan, Karen Crawford, Sureyya Dikmen, Ann-Christine Duhaime, Richard Ellenbogen, V Ramana Feeser, Adam R. Ferguson, Brandon Foreman, Raquel Gardner, Etienne Gaudette, Joseph Giacino, Luis Gonzalez, Shankar Gopinath, Rao Gullapalli, J Claude Hemphill, Gillian Hotz, Joel Kramer, Natalie Kreitzer, Harvey Levin, Chris Lindsell, Joan Machamer, Christopher Madden, Alastair Martin, Thomas McAllister, Michael McCrea, Randall Merchant, Lindsay Nelson, Laura Ngwenya, Eva Palacios, Daniel Perl, Miri Rabinowitz, Jonathan Rosand, Angelle Sander, Gabriella Satris, David Schnyer, Seth Seabury, Arthur Toga, Alex Valadka, Mary Vassar, Paul Vespa, and Ross Zafonte
- Subjects
TBI ,Biomarkers ,UCH-L1 ,Point of care ,Mild TBI ,NSE ,Toxicology. Poisons ,RA1190-1270 ,Biotechnology ,TP248.13-248.65 ,Biology (General) ,QH301-705.5 - Abstract
The use of UCH-L1 detection with point-of-care (POC) assay alone has not been characterized for clinical use. This study compares the accuracies of POC UCH-L1 and Neuron-Specific Enolase (NSE) Elecsys® levels for identifying TBI patients with structural abnormalities on neuroimaging.The Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Phase 1 Cohort, enrolled 1375 TBI patients (GCS 3–15) presenting to one of 18 US Level I trauma centers within 24 h of injury who had an admission head CT; blood samples were collected, along with 122 orthopedic and 209 healthy controls. The TBI cohort consisted of 810 CT-negative (CT-) and 549 CT-positive (CT+) subjects. Of the CT- subjects who had MRIs, 121 were MRI-positive (MRI+) and 333 were MRI-negative (MRI-). UCH-L1 POC showed best diagnostic performance for CT + versus CT-, 0–8 h post-injury with an AUC of 0·779 [0·708–0.850] when compared to the 0–25 h interval, with an AUC of 0.684 [0.655–0.712]. NSE assay has an AUC of 0.695 [0.619–0.770] for the 0–8 h interval and 0.634 [0.603–0.665] for the 0–25 h interval. During the first 8 after injury, POC UCH-L1 outperforms NSE in identifying TBI patients with structural abnormalities on neuroimaging.
- Published
- 2023
- Full Text
- View/download PDF
11. A standardized postoperative bowel regimen protocol after spine surgery
- Author
-
John K. Yue, Nishanth Krishnan, Albert S. Wang, Jason E. Chung, Leila L. Etemad, Geoffrey T. Manley, and Phiroz E. Tarapore
- Subjects
clinical protocol ,cost effectiveness ,gastrointestinal motility ,ileus ,postoperative care ,quality of care ,Surgery ,RD1-811 - Abstract
ObjectivesSpine surgery is associated with early impairment of gastrointestinal motility, with postoperative ileus rates of 5–12%. A standardized postoperative medication regimen aimed at early restoration of bowel function can reduce morbidity and cost, and its study should be prioritized.MethodsA standardized postoperative bowel medication protocol was implemented for all elective spine surgeries performed by a single neurosurgeon from March 1, 2022 to June 30, 2022 at a metropolitan Veterans Affairs medical center. Daily bowel function was tracked and medications were advanced using the protocol. Clinical, surgical, and length of stay data are reported.ResultsAcross 20 consecutive surgeries in 19 patients, mean age was 68.9 years [standard deviation (SD) = 10; range 40–84]. Seventy-four percent reported preoperative constipation. Surgeries consisted of 45% fusion and 55% decompression; lumbar retroperitoneal approaches constituted 30% (10% anterior, 20% lateral). Two patients were discharged in good condition prior to bowel movement after meeting institutional discharge criteria; the other 18 cases all had return of bowel function by postoperative day (POD) 3 (mean = 1.8-days, SD = 0.7). There were no inpatient or 30-day complications. Mean discharge occurred 3.3-days post-surgery (SD = 1.5; range 1–6; home 95%, skilled nursing facility 5%). Estimated cumulative cost of the bowel regimen was $17 on POD 3.ConclusionsCareful monitoring of return of bowel function after elective spine surgery is important for preventing ileus, reducing healthcare cost, and ensuring quality. Our standardized postoperative bowel regimen was associated with return of bowel function within 3 days and low costs. These findings can be utilized in quality-of-care pathways.
- Published
- 2023
- Full Text
- View/download PDF
12. Power Drill Craniostomy for Bedside Intracranial Access in Traumatic Brain Injury Patients
- Author
-
Hansen Deng, David J. Puccio, Sharath K. Anand, John K. Yue, Joseph S. Hudson, Andrew D. Legarreta, Zhishuo Wei, David O. Okonkwo, Ava M. Puccio, and Enyinna L. Nwachuku
- Subjects
craniofacial trauma ,craniostomy ,external ventricular drain ,multimodality monitoring ,power drill ,traumatic brain injury ,Medicine (General) ,R5-920 - Abstract
Invasive neuromonitoring is a bedrock procedure in neurosurgery and neurocritical care. Intracranial hypertension is a recognized emergency that can potentially lead to herniation, ischemia, and neurological decline. Over 50,000 external ventricular drains (EVDs) are performed in the United States annually for traumatic brain injuries (TBI), tumors, cerebrovascular hemorrhaging, and other causes. The technical challenge of a bedside ventriculostomy and/or parenchymal monitor placement may be increased by complex craniofacial trauma or brain swelling, which will decrease the tolerance of brain parenchyma to applied procedural force during a craniostomy. Herein, we report on the implementation and safety of a disposable power drill for bedside neurosurgical practices compared with the manual twist drill that is the current gold standard. Mechanical testing of the drill’s stop extension (n = 8) was conducted through a calibrated tensile tester, simulating an axial plunging of 22.68 kilogram (kg) or 50 pounds of force (lbf) and measuring the strength-responsive displacement. The mean displacement following compression was 0.18 ± 0.11 mm (range of 0.03 mm to 0.34 mm). An overall cost analysis was calculated based on the annual institutional pricing, with an estimated $64.90 per unit increase in the cost of the disposable electric drill. Power drill craniostomies were utilized in a total of 34 adult patients, with a median Glasgow Coma Scale (GCS) score of six. Twenty-seven patients were male, with a mean age of 50.7 years old. The two most common injury mechanisms were falls and motor vehicle/motorcycle accidents. EVDs were placed in all subjects, and additional quad-lumen neuromonitoring was applied to 23 patients, with no incidents of plunging events or malfunctions. One patient developed an intracranial infection and another had intraparenchymal tract hemorrhaging. Two illustrative TBI cases with concomitant craniofacial trauma were provided. The disposable power drill was successfully implemented as an option for bedside ventriculostomies and had an acceptable safety profile.
- Published
- 2023
- Full Text
- View/download PDF
13. A Case of Torticollis in an 8-Month-Old Infant Caused by Posterior Fossa Arachnoid Cyst: An Important Entity for Differential Diagnosis
- Author
-
John K. Yue, Taemin Oh, Kasey J. Han, Diana Chang, and Peter P. Sun
- Subjects
arachnoid cyst ,differential diagnosis ,posterior fossa ,torticollis ,Medicine ,Pediatrics ,RJ1-570 - Abstract
Torticollis is a clinical diagnosis with heterogeneous causes. We present an unusual case of acquired torticollis in an 8-month-old female infant with a large cerebellopontine angle arachnoid cyst. Symptoms resolved after surgical fenestration. Non-traumatic acquired or new-onset torticollis requires brain imaging, and posterior fossa lesions are an important entity in the differential for pediatric clinicians.
- Published
- 2021
- Full Text
- View/download PDF
14. Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease
- Author
-
Naila Rabbani, Antonysunil Adaikalakoteswari, James R. Larkin, Sianna Panagiotopoulos, Richard J. MacIsaac, Dennis K. Yue, Gregory R. Fulcher, Matthew A. Roberts, Merlin Thomas, Elif Ekinci, and Paul J. Thornalley
- Subjects
chronic kidney disease ,diabetes ,glycation ,methylglyoxal ,estimated glomerular filtration rate ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
Accumulation of advanced glycation endproducts (AGEs) is linked to decline in renal function, particularly in patients with diabetes. Major forms of AGEs in serum are protein-bound AGEs and AGE free adducts. In this study, we assessed levels of AGEs in subjects with and without diabetes, with normal renal function and stages 2 to 4 chronic kidney disease (CKD), to identify which AGE has the greatest progressive change with decline in renal function and change in diabetes. We performed a cross-sectional study of patients with stages 2–4 CKD, with and without diabetes, and healthy controls (n = 135). Nine protein-bound and free adduct AGEs were quantified in serum. Most protein-bound AGEs increased moderately through stages 2–4 CKD whereas AGE free adducts increased markedly. Methylglyoxal-derived hydroimidazolone MG-H1 free adduct was the AGE most responsive to CKD status, increasing 8-fold and 30-fold in stage 4 CKD in patients without and with diabetes, respectively. MG-H1 Glomerular filtration flux was increased 5-fold in diabetes, likely reflecting increased methylglyoxal glycation status. We conclude that serum MG-H1 free adduct concentration was strongly related to stage of CKD and increased in diabetes status. Serum MG-H1 free adduct is a candidate AGE risk marker of non-diabetic and diabetic CKD.
- Published
- 2022
- Full Text
- View/download PDF
15. Targeting Melanocortin Receptors Using SNAr-Type Macrocyclization: A Doubly Orthogonal Route to Cyclic Peptide Conjugates
- Author
-
Wenxiao K. Yue, Tianxia Zhang, Rekha Shandre Mugan, Nicholas Barlow, David K. Chalmers, Colin W. Pouton, and Philip E. Thompson
- Subjects
Drug Discovery ,Molecular Medicine - Published
- 2023
16. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study
- Author
-
Frederick K Korley, Sonia Jain, Xiaoying Sun, Ava M Puccio, John K Yue, Raquel C Gardner, Kevin K W Wang, David O Okonkwo, Esther L Yuh, Pratik Mukherjee, Lindsay D Nelson, Sabrina R Taylor, Amy J Markowitz, Ramon Diaz-Arrastia, Geoffrey T Manley, Opeolu Adeoye, Neeraj Badatjia, Ann-Christine Duhaime, Adam Ferguson, Brandon Foreman, Joseph T Giacino, Shankar Gopinath, Ramesh Grandhi, Ryan Kitagawa, Christopher Madden, Randall Merchant, Mike McCrea, Laura Ngwenya, Miri Rabinowitz, Claudia Robertson, David Schnyer, Murray Stein, Mary Vassar, Vincent Wang, Alex Valadka, and Ross Zafonte
- Subjects
Neurology (clinical) - Published
- 2022
17. Outcome Prediction in Patients with Severe Traumatic Brain Injury Using Deep Learning from Head CT Scans
- Author
-
Matthew, Pease, Dooman, Arefan, Jason, Barber, Esther, Yuh, Ava, Puccio, Kerri, Hochberger, Enyinna, Nwachuku, Souvik, Roy, Stephanie, Casillo, Nancy, Temkin, David O, Okonkwo, Shandong, Wu, and John K, Yue
- Subjects
Adult ,Male ,Deep Learning ,Brain Injuries, Traumatic ,Humans ,Glasgow Coma Scale ,Radiology, Nuclear Medicine and imaging ,Prognosis ,Tomography, X-Ray Computed ,Retrospective Studies - Abstract
Background After severe traumatic brain injury (sTBI), physicians use long-term prognostication to guide acute clinical care yet struggle to predict outcomes in comatose patients. Purpose To develop and evaluate a prognostic model combining deep learning of head CT scans and clinical information to predict long-term outcomes after sTBI. Materials and Methods This was a retrospective analysis of two prospectively collected databases. The model-building set included 537 patients (mean age, 40 years ± 17 [SD]; 422 men) from one institution from November 2002 to December 2018. Transfer learning and curriculum learning were applied to a convolutional neural network using admission head CT to predict mortality and unfavorable outcomes (Glasgow Outcomes Scale scores 1-3) at 6 months. This was combined with clinical input for a holistic fusion model. The models were evaluated using an independent internal test set and an external cohort of 220 patients with sTBI (mean age, 39 years ± 17; 166 men) from 18 institutions in the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study from February 2014 to April 2018. The models were compared with the International Mission on Prognosis and Analysis of Clinical Trials in TBI (IMPACT) model and the predictions of three neurosurgeons. Area under the receiver operating characteristic curve (AUC) was used as the main model performance metric. Results The fusion model had higher AUCs than did the IMPACT model in the prediction of mortality (AUC, 0.92 [95% CI: 0.86, 0.97] vs 0.80 [95% CI: 0.71, 0.88]
- Published
- 2022
18. Time to Follow Commands in Severe Traumatic Brain Injury Survivors With Favorable Recovery at 2 Years
- Author
-
Hansen, Deng, Enyinna L, Nwachuku, Tiffany E, Wilkins, John K, Yue, Anita, Fetzick, Yue-Fang, Chang, Sue R, Beers, David O, Okonkwo, and Ava M, Puccio
- Subjects
Adult ,Aged, 80 and over ,Adolescent ,Glasgow Outcome Scale ,Diffuse Axonal Injury ,Middle Aged ,Young Adult ,Brain Injuries, Traumatic ,Humans ,Glasgow Coma Scale ,Surgery ,Survivors ,Neurology (clinical) ,Aged ,Cerebral Hemorrhage - Abstract
The recovery of severe traumatic brain injury (TBI) survivors with long-term favorable outlook is understudied. Time to follow commands varies widely in this patient population but has important clinical implications.To (1) evaluate time to follow commands in severe patients with TBI with favorable outcomes, (2) characterize their trajectory of recovery, and (3) identify predictors associated with delayed cognitive improvement.Participants were recruited prospectively at a Level I trauma center through the Brain Trauma Research Center from 2003 to 2018. Inclusion criteria were age 16 to 80 years, Glasgow Coma Scale score ≤8 and motor scorelt;6, and Glasgow Outcome Scale-Extended measure ≥4 at 2 years postinjury.In 580 patients, there were 229 (39.5%) deaths and 140 (24.1%) patients had favorable outcomes at 2 years. The mean age was 33.7 ± 14.5 years, median Glasgow Coma Scale was 7 (IQR 6-7), and median Injury Severity Score was 30 (IQR 26-38). The mean time to follow commands was 12.7 ± 11.8 days. On multivariable linear regression, the presence of diffuse axonal injury (B = 9.2 days [4.8, 13.7], Plt; .0001) or intraventricular hemorrhage (B = 6.4 days [0.5, 12.3], Plt; .035) was associated with longer time before following commands and patients who developed nosocomial infections (B = 6.5 days [1.6-11.4], Plt; .01).In severe TBI survivors with favorable outcomes, time to follow commands varied widely. Most patients began to follow commands within 2 weeks. Evidence of diffuse axonal injury, intraventricular hemorrhage, and infections can delay cognitive improvement in the acute period. Patients make considerable recovery up to 2 years after their injury.
- Published
- 2022
19. Update on Pediatric Mild Traumatic Brain Injury in Rural and Underserved Regions: A Global Perspective
- Author
-
John K. Yue, Nishanth Krishnan, John P. Andrews, Alexa M. Semonche, Hansen Deng, Alexander A. Aabedi, Albert S. Wang, David J. Caldwell, Christine Park, Melessa Hirschhorn, Kristen T. Ghoussaini, Taemin Oh, and Peter P. Sun
- Subjects
Pediatric ,Physical Injury - Accidents and Adverse Effects ,brain concussion ,Clinical Sciences ,evidence-based practice ,Neurosciences ,8.1 Organisation and delivery of services ,socioeconomic factors ,General Medicine ,Rural Health ,Traumatic Brain Injury (TBI) ,Health Services ,healthcare disparities ,Brain Disorders ,Quality Education ,Good Health and Well Being ,Clinical Research ,mild traumatic brain injury ,Behavioral and Social Science ,epidemiology ,telemedicine ,medically underserved area ,Traumatic Head and Spine Injury ,Health and social care services research - Abstract
Background: Mild traumatic brain injury (MTBI) causes morbidity and disability worldwide. Pediatric patients are uniquely vulnerable due to developmental and psychosocial factors. Reduced healthcare access in rural/underserved communities impair management and outcome. A knowledge update relevant to current gaps in care is critically needed to develop targeted solutions. Methods: The National Library of Medicine PubMed database was queried using comprehensive search terms ((“mild traumatic brain injury” or “concussion”) and (“rural” or “low-income” or “underserved”) and (“pediatric” or “child/children”)) in the title, abstract, and Medical Subject Headings through December 2022. Fifteen articles on rural/underserved pediatric MTBI/concussion not covered in prior reviews were examined and organized into four topical categories: epidemiology, care practices, socioeconomic factors, and telehealth. Results: Incidences are higher for Individuals in rural regions, minorities, and those aged 0–4 years compared to their counterparts, and are increasing over time. Rural healthcare utilization rates generally exceed urban rates, and favor emergency departments (vs. primary care) for initial injury assessment. Management guidelines require customization to resource-constrained settings for implementation and adoption. Decreased community recognition of the seriousness of injury is a consensus challenge to care provision by clinicians. Low parental education and income were correlated with decreased MTBI knowledge and worse outcome. Telehealth protocols for triage/consultation and rehabilitation were feasible in improving care delivery to rural and remote settings. Conclusions: Pediatric MTBI/concussion patients in rural/underserved regions experience increased risks of injury, geographic and financial healthcare barriers, and poorer outcomes. Globally, under-reporting of injury has hindered epidemiological understanding. Ongoing MTBI education should be implemented for rural caregivers, schools, and low-income populations to improve community awareness. Telehealth can improve care delivery across acuity settings, and warrants judicious inclusion in triage and treatment protocols.
- Published
- 2023
20. Traumatic Brain Injury: Contemporary Challenges and the Path to Progress
- Author
-
John K. Yue and Hansen Deng
- Subjects
Clinical Sciences ,General Medicine - Abstract
Traumatic brain injury (TBI) remains a leading cause of death and disability worldwide, and its incidence is increasing [...]
- Published
- 2023
21. Socioeconomic and Clinical Factors Associated With Prolonged Hospital Length of Stay After Traumatic Brain Injury
- Author
-
John K. Yue, Nishanth Krishnan, Lawrence Chyall, Paloma Vega, Sabah Hamidi, Leila L. Etemad, Joye X. Tracey, Phiroz E. Tarapore, Michael C. Huang, Geoffrey T. Manley, and Anthony M. DiGiorgio
- Subjects
General Earth and Planetary Sciences ,General Environmental Science - Published
- 2023
22. The Hybrid Operative Suite with Intraoperative Biplane Rotational Angiography in Pediatric Cerebrovascular Neurosurgery: Utility and Lessons Learned
- Author
-
John K. Yue, Diana Chang, Michael Travis Caton Jr., Alexander F. Haddad, Cecilia L. Dalle Ore, Thomas A. Wozny, Taemin Oh, Albert S. Wang, Daniel A. Tonetti, Kurtis I. Auguste, Peter P. Sun, Daniel L. Cooke, Steven W. Hetts, Adib A. Abla, Nalin Gupta, and Jarod L. Roland
- Subjects
Adult ,Central Nervous System Vascular Malformations ,Adolescent ,Endovascular Procedures ,Neurosurgery ,Angiography, Digital Subtraction ,General Medicine ,Neurosurgical Procedures ,Young Adult ,Pediatrics, Perinatology and Child Health ,Humans ,Surgery ,Neurology (clinical) ,Child - Abstract
Introduction: The benefits of performing open and endovascular procedures in a hybrid neuroangiography surgical suite include confirmation of treatment results and reduction in number of procedures, leading to improved efficiency of care. Combined procedural suites are infrequently used in pediatric facilities due to technical and logistical limitations. We report the safety, utility, and lessons learned from a single-institution experience using a hybrid suite equipped with biplane rotational digital subtraction angiography and pan-surgical capabilities. Methods: We conducted a retrospective review of consecutive cases performed at our institution that utilized the hybrid neuroangiography surgical suite from February 2020 to August 2021. Demographics, surgical metrics, and imaging results were collected from the electronic medical record. Outcomes, interventions, and nuances for optimizing preoperative/intraoperative setup and postoperative care were presented. Results: Eighteen procedures were performed in 17 patients (mean age 13.4 years, range 6–19). Cases included 14 arteriovenous malformations (AVM; 85.7% ruptured), one dural arteriovenous fistula, one mycotic aneurysm, and one hemangioblastoma. The average operative time was 416 min (range 321–745). There were no intraoperative or postoperative complications. All patients were alive at follow-up (range 0.1–14.7 months). Five patients had anticipated postoperative deficits arising from their hemorrhage, and 12 returned to baseline neurological status. Four illustrative cases demonstrating specific, unique applications of the hybrid angiography suite are presented. Conclusion: The hybrid neuroangiography surgical suite is a safe option for pediatric cerebrovascular pathologies requiring combined surgical and endovascular intervention. Hybrid cases can be completed within the same anesthesia session and reduce the need for return to the operating room for resection or surveillance angiography. High-quality intraoperative angiography enables diagnostic confirmation under a single procedure, mitigating risk of morbidity and accelerating recovery. Effective multidisciplinary planning enables preoperative angiograms to be completed to inform the operative plan immediately prior to definitive resection.
- Published
- 2022
23. Matter radius determination of $$^{16}$$O via small-angle differential cross sections
- Author
-
Y. Huang, J. T. Zhang, Y. Kuang, J. Geng, X. L. Tu, K. Yue, W. H. Long, and Z. P. Li
- Subjects
Nuclear and High Energy Physics - Published
- 2023
24. B-Cell Lymphoma 2 (Bcl-2) and Regulation of Apoptosis after Traumatic Brain Injury: A Clinical Perspective
- Author
-
Hansen Deng, John K. Yue, Benjamin E. Zusman, Enyinna L. Nwachuku, Hussam Abou-Al-Shaar, Pavan S. Upadhyayula, David O. Okonkwo, and Ava M. Puccio
- Subjects
Bcl-2 ,Bax ,Bcl-xL ,apoptosis ,programmed cell death ,traumatic brain injury ,Medicine (General) ,R5-920 - Abstract
Background and Objectives: The injury burden after head trauma is exacerbated by secondary sequelae, which leads to further neuronal loss. B-cell lymphoma 2 (Bcl-2) is an anti-apoptotic protein and a key modulator of the programmed cell death (PCD) pathways. The current study evaluates the clinical evidence on Bcl-2 and neurological recovery in patients after traumatic brain injury (TBI). Materials and Methods: All studies in English were queried from the National Library of Medicine PubMed database using the following search terms: (B-cell lymphoma 2/Bcl-2/Bcl2) AND (brain injury/head injury/head trauma/traumatic brain injury) AND (human/patient/subject). There were 10 investigations conducted on Bcl-2 and apoptosis in TBI patients, of which 5 analyzed the pericontutional brain tissue obtained from surgical decompression, 4 studied Bcl-2 expression as a biomarker in the cerebrospinal fluid (CSF), and 1 was a prospective randomized trial. Results: Immunohistochemistry (IHC) in 94 adults with severe TBI showed upregulation of Bcl-2 in the pericontusional tissue. Bcl-2 was detected in 36–75% of TBI patients, while it was generally absent in the non-TBI controls, with Bcl-2 expression increased 2.9- to 17-fold in TBI patients. Terminal deoxynucleotidyl transferase-mediated biotinylated dUTP nick-end labeling (TUNEL) positivity for cell death was detected in 33–73% of TBI patients. CSF analysis in 113 TBI subjects (90 adults, 23 pediatric patients) showed upregulation of Bcl-2 that peaked on post-injury day 3 and subsequently declined after day 5. Increased Bcl-2 in the peritraumatic tissue, rising CSF Bcl-2 levels, and the variant allele of rs17759659 are associated with improved mortality and better outcomes on the Glasgow Outcome Score (GOS). Conclusions: Bcl-2 is upregulated in the pericontusional brain and CSF in the acute period after TBI. Bcl-2 has a neuroprotective role as a pro-survival protein in experimental models, and increased expression in patients can contribute to improvement in clinical outcomes. Its utility as a biomarker and therapeutic target to block neuronal apoptosis after TBI warrants further evaluation.
- Published
- 2020
- Full Text
- View/download PDF
25. Paraparesis caused by intradural thoracic spinal granuloma secondary to organizing hematoma: illustrative case
- Author
-
John K, Yue, Young M, Lee, Daniel, Quintana, Alexander A, Aabedi, Nishanth, Krishnan, Thomas A, Wozny, John P, Andrews, and Michael C, Huang
- Subjects
spine surgery ,neurocritical care ,inflammation ,spinal granuloma ,intradural hematoma ,General Medicine ,Cardiovascular ,spinal cord injury - Abstract
BACKGROUND Spinal granulomas form from infectious or noninfectious inflammatory processes and are rarely present intradurally. Intradural granulomas secondary to hematoma are unreported in the literature and present diagnostic and management challenges. OBSERVATIONS A 70-year-old man receiving aspirin presented with encephalopathy, subacute malaise, and right lower extremity weakness and was diagnosed with polysubstance withdrawal and refractory hypertension requiring extended treatment. Seven days after admission, he reported increased bilateral lower extremity (BLE) weakness. Magnetic resonance imaging showed T2–3 and T7–8 masses abutting the pia, with spinal cord compression at T2–3. He was transferred to the authors’ institution, and work-up showed no vascular shunting or malignancy. He underwent T2–3 laminectomies for biopsy/resection. A firm, xanthochromic mass was resected en bloc. Pathology showed organizing hematoma without infection, vascular malformation, or malignancy. Subsequent coagulopathy work-up was unremarkable. His BLE strength significantly improved, and he declined resection of the inferior mass. He completed physical therapy and was cleared for placement in a skilled nursing facility. LESSONS Spinal granulomas can mimic vascular lesions and malignancy. The authors present the first report of paraparesis caused by intradural granuloma secondary to organizing hematoma, preceded by severe refractory hypertension. Tissue diagnosis is critical, and resection is curative. These findings can inform the vigilant clinician for expeditious treatment.
- Published
- 2022
26. Feasibility and Utility of a Flexible Outcome Assessment Battery for Longitudinal Traumatic Brain Injury Research: A TRACK-TBI Study
- Author
-
Yelena G, Bodien, Jason, Barber, Sabrina R, Taylor, Kim, Boase, John D, Corrigan, Sureyya, Dikmen, Raquel C, Gardner, Joel H, Kramer, Harvey, Levin, Joan, Machamer, Thomas, McAllister, Lindsay D, Nelson, Laura B, Ngwenya, Mark, Sherer, Murray B, Stein, Mary, Vassar, John, Whyte, John K, Yue, Amy, Markowitz, Michael A, McCrea, Geoffrey T, Manley, Nancy, Temkin, and Joseph T, Giacino
- Abstract
The effects of traumatic brain injury (TBI) are difficult to measure in longitudinal cohort studies, because disparate pre-injury characteristics and injury mechanisms produce variable impairment profiles and recovery trajectories. In preparation for the Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) study, which followed patients with injuries ranging from uncomplicated mild TBI to coma, we designed a multi-dimensional Flexible outcome Assessment Battery (FAB). The FAB relies on a decision-making algorithm that assigns participants to a Comprehensive (CAB) or Abbreviated Assessment Battery (AAB) and guides test selection across all phases of recovery. To assess feasibility of the FAB, we calculated the proportion of participants followed at 2 weeks (2w) and at 3, 6, and 12 months (3m, 6m, 12m) post-injury who completed the FAB and received valid scores. We evaluated utility of the FAB by examining differences in 6m and 12m Glasgow Outcome Scale-Extended (GOSE) scores between participant subgroups derived from the FAB-enabled versus traditional approach to outcome assessment applied at 2w. Among participants followed at 2w (
- Published
- 2022
27. Emotional Resilience Predicts Preserved White Matter Microstructure Following Mild Traumatic Brain Injury
- Author
-
Lanya T. Cai, Benjamin L. Brett, Eva M. Palacios, Esther L. Yuh, Ioanna Bourla, Jamie Wren-Jarvis, Yang Wang, Christine Mac Donald, Ramon Diaz-Arrastia, Joseph T. Giacino, David O. Okonkwo, Harvey S. Levin, Claudia S. Robertson, Nancy Temkin, Amy J. Markowitz, Geoffrey T. Manley, Murray B. Stein, Michael A. McCrea, Ross D. Zafonte, Lindsay D. Nelson, Pratik Mukherjee, Adam R. Ferguson, Sabrina R. Taylor, John K. Yue, Ruchira Jha, Shankar Gopinath, Sonia Jain, Laura B. Ngwenya, Neeraj Badjatia, Rao Gullapalli, Frederick K. Korley, Ava M. Puccio, David Schnyer, Christopher Madden, Ramesh Grandhi, C. Dirk Keene, and Randall Merchant
- Subjects
Cognitive Neuroscience ,Radiology, Nuclear Medicine and imaging ,Neurology (clinical) ,Biological Psychiatry - Abstract
Adult patients with mild traumatic brain injury (mTBI) exhibit distinct phenotypes of emotional and cognitive functioning identified by latent profile analysis of clinical neuropsychological assessments. When discerned early after injury, these latent clinical profiles have been found to improve prediction of long-term outcomes from mTBI. The present study hypothesized that white matter (WM) microstructure is better preserved in an emotionally resilient (ER) mTBI phenotype compared with a neuropsychiatrically distressed (ND) mTBI phenotype.The present study used diffusion MRI to investigate and compare WM microstructure in major association, projection, and commissural tracts between the two phenotypes and over time. Diffusion MR images from 172 mTBI patients were analyzed to compute individual diffusion tensor imaging (DTI) maps at 2 weeks and 6 months postinjury.By comparing the DTI parameters between the two phenotypes at global, regional, and voxel levels, the present study showed that the ER patients have higher axial diffusivity (AD) compared to their ND counterparts early after mTBI. Longitudinal analysis revealed greater compromise of WM microstructure in ND patients, with greater decrease of global AD and more widespread decrease of regional AD during the first 6 months after injury compared to their ER counterparts.These results provide neuroimaging evidence of WM microstructural differences underpinning mTBI phenotypes identified from neuropsychological assessments and show differing longitudinal trajectories of these biological effects. These findings suggest diffusion MRI can provide short- and long-term imaging biomarkers of resilience.
- Published
- 2022
28. Outcomes in Patients With Mild Traumatic Brain Injury Without Acute Intracranial Traumatic Injury
- Author
-
Debbie Y, Madhok, Robert M, Rodriguez, Jason, Barber, Nancy R, Temkin, Amy J, Markowitz, Natalie, Kreitzer, Geoffrey T, Manley, and John K, Yue
- Subjects
Adult ,Cohort Studies ,Male ,Brain Injuries, Traumatic ,Humans ,Glasgow Coma Scale ,General Medicine ,Prospective Studies ,Brain Concussion - Abstract
Traumatic brain injury (TBI) affects millions of people in the US each year. Most patients with TBI seen in emergency departments (EDs) have a Glasgow Coma Scale (GCS) score of 15 and a head computed tomography (CT) scan showing no acute intracranial traumatic injury (negative head CT scan), yet the short-term and long-term functional outcomes of this subset of patients remain unclear.To describe the 2-week and 6-month recovery outcomes in a cohort of patients with mild TBI with a GCS score of 15 and a negative head CT scan.This cohort study analyzed participants who were enrolled from January 1, 2014, to December 31, 2018, in the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study, a prospective, observational cohort study of patients with TBI that was conducted in EDs of 18 level I trauma centers in urban areas. Of the total 2697 participants in the TRACK-TBI study, 991 had a GCS score of 15 and negative head CT scan and were eligible for inclusion in this analysis. Data were analyzed from September 1, 2021, to May 30, 2022.The primary outcome was the Glasgow Outcome Scale-Extended (GOS-E) score, which was stratified according to functional recovery (GOS-E score, 8) vs incomplete recovery (GOS-E score,8), at 2 weeks and 6 months after the injury. The secondary outcome was severity of mild TBI-related symptoms assessed by the Rivermead Post Concussion Symptoms Questionnaire (RPQ) total score.A total of 991 participants (mean [SD] age, 38.5 [15.8] years; 631 male individuals [64%]) were included. Of these participants, 751 (76%) were followed up at 2 weeks after the injury: 204 (27%) had a GOS-E score of 8 (functional recovery), and 547 (73%) had a GOS-E scores less than 8 (incomplete recovery). Of 659 participants (66%) followed up at 6 months after the injury, 287 (44%) had functional recovery and 372 (56%) had incomplete recovery. Most participants with incomplete recovery reported that they had not returned to baseline or preinjury life (88% [479 of 546]; 95% CI, 85%-90%). Mean RPQ score was 16 (95% CI, 14-18; P .001) points lower at 2 weeks (7 vs 23) and 18 (95% CI, 16-20; P .001) points lower at 6 months (4 vs 22) in participants with a GOS-E score of 8 compared with those with a GOS-E score less than 8.This study found that most participants with a GCS score of 15 and negative head CT scan reported incomplete recovery at 2 weeks and 6 months after their injury. The findings suggest that emergency department clinicians should recommend 2-week follow-up visits for these patients to identify those with incomplete recovery and to facilitate their rehabilitation.
- Published
- 2022
29. Predictors of Extreme Hospital Length of Stay After Traumatic Brain Injury
- Author
-
John K. Yue, Nishanth Krishnan, Lawrence Chyall, Alexander F. Haddad, Paloma Vega, David J. Caldwell, Gray Umbach, Evelyne Tantry, Phiroz E. Tarapore, Michael C. Huang, Geoffrey T. Manley, and Anthony M. DiGiorgio
- Subjects
Surgery ,Neurology (clinical) - Abstract
Hospital length of stay (HLOS) after traumatic brain injury (TBI) is an important metric of injury severity, resource utilization, and access to post-acute care services. Risk factors for protracted HLOS after TBI require further characterization.Data regarding adult inpatients admitted to a single U.S. level 1 trauma center with a diagnosis of acute TBI between August 1, 2019, and April 1, 2022, were extracted from the electronic health record. Patients with extreme HLOS (XHLOS,99th percentile of institutional TBI HLOS) were compared with those without XHLOS. Socioeconomic status (SES), clinical/injury factors, and discharge disposition were analyzed.In 1638 patients, the median HLOS was 3 days (interquartile range [IQR]: 2-8 days). XHLOS threshold was70 days (N = 18; range: 72-146 days). XHLOS was associated with younger age (XHLOS/non-XHLOS: 50.4/59.6 years; P = 0.042) and greater proportions with severe TBI (55.6%/11.4%; P0.001), low SES (72.2%/31.4%; P0.001), and Medicaid insurance (77.8%/30.1%; P0.001). XHLOS patients were more likely to die in hospital (22.2%/8.1%) and discharge to post-acute facility (77.8%/16.3%; P0.001). No XHLOS patients were discharged to home. In XHLOS patients alive at discharge, medical stability was documented at median 39 days (IQR: 28-58 days) and were hospitalized for another 56 days (IQR: 26.5-78.5 days).XHLOS patients were more likely to have severe injuries, low SES, and Medicaid. XHLOS is associated with in-hospital mortality and need for post-acute placement. XHLOS patients often demonstrated medical stability long before placement, underscoring complex relationships between SES, health insurance, and outcome. These findings have important implications for quality improvement and resource utilization at acute care hospitals and await validation from larger trials.
- Published
- 2022
30. Mutational landscape of normal epithelial cells in Lynch Syndrome patients
- Author
-
Bernard C. H. Lee, Philip S. Robinson, Tim H. H. Coorens, Helen H. N. Yan, Sigurgeir Olafsson, Henry Lee-Six, Mathijs A. Sanders, Hoi Cheong Siu, James Hewinson, Sarah S. K. Yue, Wai Yin Tsui, Annie S. Y. Chan, Anthony K. W. Chan, Siu Lun Ho, Peter J. Campbell, Inigo Martincorena, Simon J. A. Buczacki, Siu Tsan Yuen, Suet Yi Leung, Michael R. Stratton, Robinson, Philip S [0000-0002-6237-7159], Coorens, Tim HH [0000-0002-5826-3554], Yan, Helen HN [0000-0001-5693-8231], Campbell, Peter J [0000-0002-3921-0510], Martincorena, Inigo [0000-0003-1122-4416], Leung, Suet Yi [0000-0001-8614-4619], Stratton, Michael R [0000-0001-6035-153X], Apollo - University of Cambridge Repository, and Hematology
- Subjects
631/67/1504/1885 ,Multidisciplinary ,45 ,article ,General Physics and Astronomy ,45/23 ,Epithelial Cells ,General Chemistry ,631/67/69 ,Colorectal Neoplasms, Hereditary Nonpolyposis ,DNA Mismatch Repair ,General Biochemistry, Genetics and Molecular Biology ,digestive system diseases ,692/4020/1503/1504/1885 ,SDG 3 - Good Health and Well-being ,631/67/68 ,Mutation ,Humans ,631/337/1427/2121 ,Germ-Line Mutation ,Phylogeny - Abstract
Lynch Syndrome (LS) is an autosomal dominant disease conferring a high risk of colorectal cancer due to germline heterozygous mutations in a DNA mismatch repair (MMR) gene. Although cancers in LS patients show elevated somatic mutation burdens, information on mutation rates in normal tissues and understanding of the trajectory from normal to cancer cell is limited. Here we whole genome sequence 152 crypts from normal and neoplastic epithelial tissues from 10 LS patients. In normal tissues the repertoire of mutational processes and mutation rates is similar to that found in wild type individuals. A morphologically normal colonic crypt with an increased mutation burden and MMR deficiency-associated mutational signatures is identified, which may represent a very early stage of LS pathogenesis. Phylogenetic trees of tumour crypts indicate that the most recent ancestor cell of each tumour is already MMR deficient and has experienced multiple cycles of clonal evolution. This study demonstrates the genomic stability of epithelial cells with heterozygous germline MMR gene mutations and highlights important differences in the pathogenesis of LS from other colorectal cancer predisposition syndromes.
- Published
- 2022
- Full Text
- View/download PDF
31. Validity of the Brief Test of Adult Cognition by Telephone in Level 1 Trauma Center Patients Six Months Post-Traumatic Brain Injury: A TRACK-TBI Study
- Author
-
Lindsay D, Nelson, Jason K, Barber, Nancy R, Temkin, Kristen, Dams-O'Connor, Sureyya, Dikmen, Joseph T, Giacino, Mark D, Kramer, Harvey S, Levin, Michael A, McCrea, John, Whyte, Yelena G, Bodien, John K, Yue, Geoffrey T, Manley, and M, Zaben
- Subjects
Adult ,Male ,030506 rehabilitation ,Time Factors ,Traumatic brain injury ,Neuropsychological Tests ,03 medical and health sciences ,Cognition ,0302 clinical medicine ,Trauma Centers ,Brain Injuries, Traumatic ,Humans ,Medicine ,Prospective Studies ,Episodic memory ,business.industry ,Discriminant validity ,Neuropsychology ,Reproducibility of Results ,Construct validity ,Original Articles ,Middle Aged ,medicine.disease ,Confirmatory factor analysis ,Telephone ,nervous system diseases ,Cognitive test ,nervous system ,Mental Recall ,Female ,Neurology (clinical) ,Cognition Disorders ,0305 other medical science ,business ,030217 neurology & neurosurgery ,Follow-Up Studies ,Clinical psychology - Abstract
Our objective was to examine the construct validity of the Brief Test of Adult Cognition by Telephone (BTACT) and its relationship to traumatic brain injury (TBI) of differing severities. Data were analyzed on 1422 patients with TBI and 170 orthopedic trauma controls (OTC) from the multi-center Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) study. Participants were assessed at 6 months post-injury with the BTACT and an in-person neuropsychological battery. We examined the BTACT's factor structure, factorial group invariance, convergent and discriminant validity, and relationship to TBI and TBI severity. Confirmatory factor analysis supported both a 1-factor model and a 2-factor model comprising correlated Episodic Memory and Executive Function (EF) factors. Both models demonstrated strict invariance across TBI severity and OTC groups. Correlations between BTACT and criterion measures suggested that the BTACT memory indices predominantly reflect verbal episodic memory, whereas the BTACT EF factor correlated with a diverse range of cognitive tests. Although the EF factor and other BTACT indices showed significant relationships with TBI and TBI severity, some group effect sizes were larger for more comprehensive in-person cognitive tests than the BTACT. The BTACT is a promising, brief, phone-based cognitive screening tool for patients with TBI. Although the BTACT's memory items appear to index verbal Episodic Memory, items that purport to assess EFs may reflect a broader array of cognitive domains. The sensitivity of the BTACT to TBI severity is lower than domain-specific neuropsychological measures, suggesting it should not be used as a substitute for comprehensive, in-person cognitive testing at 6 months post-TBI.
- Published
- 2021
32. A Case of Torticollis in an 8-Month-Old Infant Caused by Posterior Fossa Arachnoid Cyst: An Important Entity for Differential Diagnosis
- Author
-
Kasey J Han, Taemin Oh, John K. Yue, Peter P. Sun, and Diana Chang
- Subjects
medicine.medical_specialty ,Posterior fossa ,lcsh:Medicine ,Case Report ,Pediatrics ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Arachnoid cyst ,Clinical Research ,arachnoid cyst ,differential diagnosis ,Medicine ,Pediatric ,Cerebellopontine angle arachnoid cyst ,screening and diagnosis ,business.industry ,lcsh:R ,Neurosciences ,lcsh:RJ1-570 ,posterior fossa ,torticollis ,lcsh:Pediatrics ,medicine.disease ,Posterior fossa arachnoid cyst ,Detection ,Clinical diagnosis ,Radiology ,Differential diagnosis ,business ,Fenestration ,030217 neurology & neurosurgery ,Torticollis ,4.2 Evaluation of markers and technologies - Abstract
Torticollis is a clinical diagnosis with heterogeneous causes. We present an unusual case of acquired torticollis in an 8-month-old female infant with a large cerebellopontine angle arachnoid cyst. Symptoms resolved after surgical fenestration. Non-traumatic acquired or new-onset torticollis requires brain imaging, and posterior fossa lesions are an important entity in the differential for pediatric clinicians.
- Published
- 2021
33. Endovascular embolization versus surgical clipping in a single surgeon series of basilar artery aneurysms: a complementary approach in the endovascular era
- Author
-
Ethan A. Winkler, Roberto Rodriguez Rubio, Mitchel S. Berger, Anthony T. Lee, S. Andrew Josephson, Kunal P. Raygor, John K. Yue, Adib A. Abla, Daniel M.S. Raper, and W. Caleb Rutledge
- Subjects
Adult ,Male ,medicine.medical_specialty ,Original Article - Vascular Neurosurgery - Aneurysm ,Microsurgery ,medicine.medical_treatment ,Clinical Sciences ,Outcomes ,Aneurysm ,Postoperative Complications ,medicine.artery ,medicine ,Basilar artery ,Humans ,Endovascular coil embolization ,Embolization ,cardiovascular diseases ,Neuroradiology ,Aged ,Neurology & Neurosurgery ,medicine.diagnostic_test ,business.industry ,Microsurgical clipping ,Endovascular Procedures ,Neurosciences ,Interventional radiology ,Intracranial Aneurysm ,Middle Aged ,medicine.disease ,Surgical Instruments ,Embolization, Therapeutic ,Surgery ,Basilar Artery ,Cohort ,cardiovascular system ,Stents ,Neurology (clinical) ,Neurosurgery ,business - Abstract
Background Currently, most basilar artery aneurysms (BAAs) are treated endovascularly. Surgery remains an appropriate therapy for a subset of all intracranial aneurysms. Whether open microsurgery would be required or utilized, and to what extent, for BAAs treated by a surgeon who performs both endovascular and open procedures has not been reported. Methods Retrospective analysis of prospectively maintained, single-surgeon series of BAAs treated with endovascular or open surgery from the first 5 years of practice. Results Forty-two procedures were performed in 34 patients to treat BAAs—including aneurysms arising from basilar artery apex, trunk, and perforators. Unruptured BAAs accounted for 35/42 cases (83.3%), and the mean aneurysm diameter was 8.4 ± 5.4 mm. Endovascular coiling—including stent-assisted coiling—accounted for 26/42 (61.9%) treatments and led to complete obliteration in 76.9% of cases. Four patients in the endovascular cohort required re-treatment. Surgical clip reconstruction accounted for 16/42 (38.1%) treatments and led to complete obliteration in 88.5% of cases. Good neurologic outcome (mRS ≤ 2) was achieved in 88.5% and 75.0% of patients in endovascular and open surgical cohorts, respectively (p = 0.40). Univariate logistic regression analysis demonstrated that advanced age (OR 1.11[95% CI 1.01–1.23]) or peri-procedural adverse event (OR 85.0 [95% CI 6.5–118.9]), but not treatment modality (OR 0.39[95% CI 0.08–2.04]), was the predictor of poor neurologic outcome. Conclusions Complementary implementation of both endovascular and open surgery facilitates individualized treatment planning of BAAs. By leveraging strengths of both techniques, equivalent clinical outcomes and technical proficiency may be achieved with both modalities.
- Published
- 2021
34. 402 Disparities in Traumatic Brain Injury Patients’ Length of Stay: An Analysis of NTDB Data
- Author
-
Evelyne Kezia Tantry, John K. Yue, Nishanth Krishnan, Oleksandr Strelko, Ergi Spiro, Phiroz E. Tarapore, Alexander F. Haddad, Michael C. Huang, Geoffrey T. Manley, and Anthony Michael DiGiorgio
- Subjects
Surgery ,Neurology (clinical) - Published
- 2023
35. 177 International Authorship Trends in Academic Neurosurgery and Effect of Double-Blind Review
- Author
-
Eric Chalif, John K. Yue, Yeshwant Chillakuru, Aarav Badani, and Manish Kumar Aghi
- Subjects
Surgery ,Neurology (clinical) - Published
- 2023
36. Multiple Tumor-Associated Intracranial Aneurysms Adjacent to a Suprasellar Germ Cell Tumor: Case Report and Review of Literature
- Author
-
Alex Y. Lu, Alyssa Reddy, Taemin Oh, Diana Chang, John K. Yue, Christine K. Fox, Steven W. Hetts, Ethan A. Winkler, Elizabeth P Young, Jarod L. Roland, and Adib A. Abla
- Subjects
Pathology ,medicine.medical_specialty ,business.industry ,Neuro oncology ,General Medicine ,Case presentation ,Clinical history ,Pediatrics, Perinatology and Child Health ,medicine ,Surgery ,Suprasellar germ cell tumor ,Neurology (clinical) ,Multiple tumors ,Aneurysm formation ,Surgical treatment ,business ,Brain neoplasm - Abstract
Introduction: Tumor-associated intracranial aneurysms are rare and not well understood. Case Presentation: We describe a 4-year-old female with multiple intracranial aneurysms intimately associated with a suprasellar germ cell tumor (GCT). We provide the clinical history, medical, and surgical treatment course, as well as a comprehensive and concise synthesis of the literature on tumor-associated aneurysms. Discussion: We discuss mechanisms for aneurysm formation with relevance to the current case, including cellular and paracrine signaling pertinent to suprasellar GCTs and possible molecular pathways involved. We review the complex multidisciplinary treatment required for complex tumor and cerebrovascular interactions.
- Published
- 2021
37. A genome-wide association study of outcome from traumatic brain injury
- Author
-
Mart Kals, Kevin Kunzmann, Livia Parodi, Farid Radmanesh, Lindsay Wilson, Saef Izzy, Christopher D. Anderson, Ava M. Puccio, David O. Okonkwo, Nancy Temkin, Ewout W. Steyerberg, Murray B. Stein, Geoff T. Manley, Andrew I.R. Maas, Sylvia Richardson, Ramon Diaz-Arrastia, Aarno Palotie, Samuli Ripatti, Jonathan Rosand, David K. Menon, Cecilia Åkerlund, Krisztina Amrein, Nada Andelic, Lasse Andreassen, Audny Anke, Anna Antoni, Gérard Audibert, Philippe Azouvi, Maria Luisa Azzolini, Ronald Bartels, Pál Barzó, Romuald Beauvais, Ronny Beer, Bo-Michael Bellander, Antonio Belli, Habib Benali, Maurizio Berardino, Luigi Beretta, Morten Blaabjerg, Peter Bragge, Alexandra Brazinova, Vibeke Brinck, Joanne Brooker, Camilla Brorsson, Andras Buki, Monika Bullinger, Manuel Cabeleira, Alessio Caccioppola, Emiliana Calappi, Maria Rosa Calvi, Peter Cameron, Guillermo Carbayo Lozano, Marco Carbonara, Simona Cavallo, Giorgio Chevallard, Arturo Chieregato, Giuseppe Citerio, Hans Clusmann, Mark Coburn, Jonathan P. Coles, Jamie D. Cooper, Marta Correia, Amra Čović, Nicola Curry, Endre Czeiter, Marek Czosnyka, Claire DahyotFizelier, Paul Dark, Helen Dawes, Véronique De Keyser, Vincent Degos, Francesco Della Corte, Hugo den Boogert, Bart Depreitere, Đula Đilvesi, Abhishek Dixit, Emma Donoghue, Jens Dreier, GuyLoup Dulière, Ari Ercole, Patrick Esser, Erzsébet Ezer, Martin Fabricius, Valery L. Feigin, Kelly Foks, Shirin Frisvold, Alex Furmanov, Pablo Gagliardo, Damien Galanaud, Dashiell Gantner, Guoyi Gao, Pradeep George, Alexandre Ghuysen, Lelde Giga, Ben Glocker, Jagoš Golubovic, Pedro A. Gomez, Johannes Gratz, Benjamin Gravesteijn, Francesca Grossi, Russell L. Gruen, Deepak Gupta, Juanita A. Haagsma, Iain Haitsma, Raimund Helbok, Eirik Helseth, Lindsay Horton, Jilske Huijben, Peter J.A. Hutchinson, Bram Jacobs, Stefan Jankowski, Mike Jarrett, Jiyao Jiang, Faye Johnson, Kelly Jones, Mladen Karan, Angelos G. Kolias, Erwin Kompanje, Daniel Kondziella, Evgenios Kornaropoulos, LarsOwe Koskinen, Noémi Kovács, Ana Kowark, Alfonso Lagares, Linda Lanyon, Steven Laureys, Fiona Lecky, Didier Ledoux, Rolf Lefering, Valerie Legrand, Aurelie Lejeune, Leon Levi, Roger Lightfoot, Hester Lingsma, Ana M. CastañoLeón, Marc Maegele, Marek Majdan, Alex Manara, Costanza Martino, Hugues Maréchal, Julia Mattern, Catherine McMahon, Béla Melegh, Tomas Menovsky, Ana Mikolic, Benoit Misset, Visakh Muraleedharan, Lynnette Murray, Ancuta Negru, David Nelson, Virginia F.J. Newcombe, Daan Nieboer, József Nyirádi, Otesile Olubukola, Matej Oresic, Fabrizio Ortolano, Paul M. Parizel, JeanFrançois Payen, Natascha Perera, Vincent Perlbarg, Paolo Persona, Wilco Peul, Anna Piippo-Karjalainen, Matti Pirinen, Dana Pisica, Horia Ples, Suzanne Polinder, Inigo Pomposo, Jussi P. Posti, Louis Puybasset, Andreea Radoi, Arminas Ragauskas, Rahul Raj, Malinka Rambadagalla, Isabel Retel Helmrich, Jonathan Rhodes, Sophie Richter, Saulius Rocka, Cecilie Roe, Olav Roise, Jeffrey V. Rosenfeld, Christina Rosenlund, Guy Rosenthal, Rolf Rossaint, Sandra Rossi, Daniel Rueckert, Martin Rusnák, Juan Sahuquillo, Oliver Sakowitz, Renan SanchezPorras, Janos Sandor, Nadine Schäfer, Silke Schmidt, Herbert Schoechl, Guus Schoonman, Rico Frederik Schou, Elisabeth Schwendenwein, Charlie Sewalt, Toril Skandsen, Peter Smielewski, Abayomi Sorinola, Emmanuel Stamatakis, Simon Stanworth, Robert Stevens, William Stewart, Nino Stocchetti, Nina Sundström, Riikka Takala, Viktória Tamás, Tomas Tamosuitis, Mark Steven Taylor, Braden Te Ao, Olli Tenovuo, Alice Theadom, Matt Thomas, Dick Tibboel, Marjolein Timmers, Christos Tolias, Tony Trapani, Cristina Maria Tudora, Andreas Unterberg, Peter Vajkoczy, Shirley Vallance, Egils Valeinis, Zoltán Vámos, Mathieu van der Jagt, Gregory van der Steen, Joukje van der Naalt, Jeroen T.J.M. van Dijck, Thomas A. van Essen, Wim Van Hecke, Caroline van Heugten, Dominique Van Praag, Ernest van Veen, Thijs Vande Vyvere, Roel P.J. van Wijk, Alessia Vargiolu, Emmanuel Vega, Kimberley Velt, Jan Verheyden, Paul M. Vespa, Anne Vik, Rimantas Vilcinis, Victor Volovici, Nicole von Steinbüchel, Daphne Voormolen, Petar Vulekovic, Kevin K.W. Wang, Eveline Wiegers, Guy Williams, Stefan Winzeck, Stefan Wolf, Zhihui Yang, Peter Ylén, Alexander Younsi, Frederick A. Zeiler, Veronika Zelinkova, Agate Ziverte, Tommaso Zoerle, Janek Frantzén, Ari Katila, Henna-Rikka Maanpää, Jussi Tallus, Opeolu Adeoye, Neeraj Badjatia, Kim Boase, Jason Barber, Yelena Bodien, Randall Chesnut, John D. Corrigan, Karen Crawford, Sureyya Dikmen, Ann-Christine Duhaime, Richard Ellenbogen, Ramana Feeser, Adam R. Ferguson, Brandon Foreman, Raquel Gardner, Etienne Gaudette, Joseph Giacino, Dana Goldman, Luis Gonzalez, Shankar Gopinath, Rao Gullapalli, Claude Hemphill, Gillian Hotz, Sonia Jain, Dirk Keene, Frederick K. Korley, Joel Kramer, Natalie Kreitzer, Harvey Levin, Chris Lindsell, Joan Machamer, Christopher Madden, Geoffrey T. Manley, Alastair Martin, Thomas McAllister, Michael McCrea, Randall Merchant, Pratik Mukherjee, Lindsay Nelson, Laura B Ngwenya, Florence Noel, Amber Nolan, David Okonkwo, Eva Palacios, Daniel Perl, Ava Puccio, Miri Rabinowitz, Claudia Robertson, Angelle Sander, Gabriella Satris, David Schnyer, Seth Seabury, Mark Sherer, Murray Stein, Sabrina Taylor, Arthur Toga, Alex Valadka, Mary Vassar, John K. Yue, Esther Yuh, Ross Zafonte, Public Health, Cell biology, Ragauskas, Arminas, Ročka, Saulius, Tamošuitis, Tomas, Vilcinis, Rimantas, Glocker, Ben, Golubovic, Jagoš, Gomez, Pedro A., Gratz, Johannes, Gravesteijn, Benjamin, Grossi, Francesca, Gruen, Russell L., Gupta, Deepak, Haagsma, Juanita A., Haitsma, Iain, Helbok, Raimund, Helseth, Eirik, Horton, Lindsay, Huijben, Jilske, Hutchinson, Peter J. A., Jacobs, Bram, Jankowski, Stefan, Jarrett, Mike, Jiang, Jiyao, Johnson, Faye, Jones, Kelly, Karan, Mladen, Kolias, Angelos G., Kompanje, Erwin, Kondziella, Daniel, Kornaropoulos, Evgenios, Koskinen, LarsOwe, Kovács, Noémi, Kowark, Ana, Lagares, Alfonso, Lanyon, Linda, Laureys, Steven, Lecky, Fiona, Ledoux, Didier, Lefering, Rolf, Legrand, Valerie, Lejeune, Aurelie, Levi, Leon, Lightfoot, Roger, Lingsma, Hester, Maas, Andrew I. R., CastañoLeón, Ana M., Maegele, Marc, Majdan, Marek, Manara, Alex, Martino, Costanza, Maréchal, Hugues, Mattern, Julia, McMahon, Catherine, Melegh, Béla, Menon, David K., Menovsky, Tomas, Mikolic, Ana, Misset, Benoit, Muraleedharan, Visakh, Murray, Lynnette, Negru, Ancuta, Nelson, David, Newcombe, Virginia F. J., Nieboer, Daan, Nyirádi, József, Olubukola, Otesile, Oresic, Matej, Ortolano, Fabrizio, Palotie, Aarno, Parizel, Paul M., Payen, JeanFrançois, Perera, Natascha, Perlbarg, Vincent, Persona, Paolo, Peul, Wilco, Piippo-Karjalainen, Anna, Pirinen, Matti, Pisica, Dana, Ples, Horia, Polinder, Suzanne, Pomposo, Inigo, Posti, Jussi P., Puybasset, Louis, Radoi, Andreea, Raj, Rahul, Rambadagalla, Malinka, Helmrich, Isabel Retel, Rhodes, Jonathan, Richardson, Sylvia, Richter, Sophie, Ripatti, Samuli, Rocka, Saulius, Roe, Cecilie, Roise, Olav, Rosenfeld, Jeffrey V., Rosenlund, Christina, Rosenthal, Guy, Rossaint, Rolf, Rossi, Sandra, Rueckert, Daniel, Rusnák, Martin, Sahuquillo, Juan, Sakowitz, Oliver, SanchezPorras, Renan, Sandor, Janos, Schäfer, Nadine, Schmidt, Silke, Schoechl, Herbert, Schoonman, Guus, Schou, Rico Frederik, Schwendenwein, Elisabeth, Sewalt, Charlie, Skandsen, Toril, Smielewski, Peter, Sorinola, Abayomi, Stamatakis, Emmanuel, Stanworth, Simon, Stevens, Robert, Stewart, William, Steyerberg, Ewout W., Stocchetti, Nino, Sundström, Nina, Takala, Riikka, Tamás, Viktória, Tamosuitis, Tomas, Taylor, Mark Steven, Ao, Braden Te, Tenovuo, Olli, Theadom, Alice, Thomas, Matt, Tibboel, Dick, Timmers, Marjolein, Tolias, Christos, Trapani, Tony, Tudora, Cristina Maria, Unterberg, Andreas, Vajkoczy, Peter, Vallance, Shirley, Valeinis, Egils, Vámos, Zoltán, van der Jagt, Mathieu, van der Steen, Gregory, van der Naalt, Joukje, van Dijck, Jeroen T. J. M., van Essen, Thomas A., Van Hecke, Wim, van Heugten, Caroline, Van Praag, Dominique, van Veen, Ernest, Vyvere, Thijs Vande, van Wijk, Roel P. J., Vargiolu, Alessia, Vega, Emmanuel, Velt, Kimberley, Verheyden, Jan, Vespa, Paul M., Vik, Anne, Volovici, Victor, von Steinbüchel, Nicole, Voormolen, Daphne, Vulekovic, Petar, Wang, Kevin K. W., Åkerlund, Cecilia, Wiegers, Eveline, Williams, Guy, Wilson, Lindsay, Winzeck, Stefan, Wolf, Stefan, Yang, Zhihui, Ylén, Peter, Younsi, Alexander, Zeiler, Frederick A., Zelinkova, Veronika, Amrein, Krisztina, Ziverte, Agate, Zoerle, Tommaso, Izzy, Saef, Radmanesh, Farid, Frantzén, Janek, Katila, Ari, Maanpää, Henna-Rikka, Tallus, Jussi, Adeoye, Opeolu, Badjatia, Neeraj, Andelic, Nada, Boase, Kim, Barber, Jason, Bodien, Yelena, Chesnut, Randall, Corrigan, John D., Crawford, Karen, Diaz-Arrastia, Ramon, Dikmen, Sureyya, Duhaime, Ann-Christine, Ellenbogen, Richard, Andreassen, Lasse, Feeser, Ramana, Ferguson, Adam R., Foreman, Brandon, Gardner, Raquel, Gaudette, Etienne, Giacino, Joseph, Goldman, Dana, Gonzalez, Luis, Gopinath, Shankar, Gullapalli, Rao, Anke, Audny, Hemphill, Claude, Hotz, Gillian, Jain, Sonia, Keene, Dirk, Korley, Frederick K., Kramer, Joel, Kreitzer, Natalie, Levin, Harvey, Lindsell, Chris, Machamer, Joan, Antoni, Anna, Madden, Christopher, Manley, Geoffrey T., Martin, Alastair, McAllister, Thomas, McCrea, Michael, Merchant, Randall, Mukherjee, Pratik, Nelson, Lindsay, Ngwenya, Laura B., Noel, Florence, Audibert, Gérard, Nolan, Amber, Okonkwo, David, Palacios, Eva, Perl, Daniel, Puccio, Ava, Rabinowitz, Miri, Robertson, Claudia, Rosand, Jonathan, Sander, Angelle, Satris, Gabriella, Azouvi, Philippe, Schnyer, David, Seabury, Seth, Sherer, Mark, Stein, Murray, Taylor, Sabrina, Temkin, Nancy, Toga, Arthur, Valadka, Alex, Vassar, Mary, Yue, John K., Azzolini, Maria Luisa, Yuh, Esther, Zafonte, Ross, Carroll, Ellen, Chatfield, Doris A., Coles, Jonathan P., Helmy, Adel, Manktelow, Anne, Outtrim, Joanne G., Bartels, Ronald, Takala, Rikka, Barzó, Pál, Beauvais, Romuald, Beer, Ronny, Bellander, Bo-Michael, Belli, Antonio, Benali, Habib, Berardino, Maurizio, Beretta, Luigi, Blaabjerg, Morten, Bragge, Peter, Brazinova, Alexandra, Brinck, Vibeke, Brooker, Joanne, Brorsson, Camilla, Buki, Andras, Bullinger, Monika, Cabeleira, Manuel, Caccioppola, Alessio, Calappi, Emiliana, Calvi, Maria Rosa, Cameron, Peter, Lozano, Guillermo Carbayo, Carbonara, Marco, Cavallo, Simona, Chevallard, Giorgio, Chieregato, Arturo, Citerio, Giuseppe, Clusmann, Hans, Coburn, Mark, Cooper, Jamie D., Correia, Marta, Čović, Amra, Curry, Nicola, Czeiter, Endre, Czosnyka, Marek, DahyotFizelier, Claire, Dark, Paul, Dawes, Helen, De Keyser, Véronique, Degos, Vincent, Corte, Francesco Della, Boogert, Hugo den, Depreitere, Bart, Đilvesi, Đula, Dixit, Abhishek, Donoghue, Emma, Dreier, Jens, Dulière, GuyLoup, Ercole, Ari, Esser, Patrick, Ezer, Erzsébet, Fabricius, Martin, Feigin, Valery L., Foks, Kelly, Frisvold, Shirin, Furmanov, Alex, Gagliardo, Pablo, Galanaud, Damien, Gantner, Dashiell, Gao, Guoyi, George, Pradeep, Ghuysen, Alexandre, Giga, Lelde, Molecular Neuroscience and Ageing Research (MOLAR), Kals, M, Kunzmann, K, Parodi, L, Radmanesh, F, Wilson, L, Izzy, S, Anderson, C, Puccio, A, Okonkwo, D, Temkin, N, Steyerberg, E, Stein, M, Manley, G, Citerio, G, Genetic Associations In Neurotrauma (GAIN) Consortium, CENTER-TBI, CABI, MGB, TBIcare Studies, TRACK-TBI, „Elsevier Science' grupė, Menon, David [0000-0002-3228-9692], Apollo - University of Cambridge Repository, Institute for Molecular Medicine Finland, Complex Disease Genetics, Research Programs Unit, Centre of Excellence in Complex Disease Genetics, Genomics of Neurological and Neuropsychiatric Disorders, Faculty Common Matters (Faculty of Social Sciences), Department of Public Health, and Biostatistics Helsinki
- Subjects
Traumatic ,Physical Injury - Accidents and Adverse Effects ,Clinical Sciences ,LOCI ,SUSCEPTIBILITY ,Traumatic Brain Injury (TBI) ,Mannose-Binding Lectin ,DISEASE ,General Biochemistry, Genetics and Molecular Biology ,Traumatic brain injury ,Consortia ,Recovery ,Brain Injuries, Traumatic ,Genetics ,2.1 Biological and endogenous factors ,Humans ,Prospective Studies ,Aetiology ,Traumatic Head and Spine Injury ,Outcome ,Human Genome ,3112 Neurosciences ,Neurosciences ,General Medicine ,LECTIN ,Brain Disorders ,Good Health and Well Being ,consortia ,genome-wide association study ,outcome ,recovery ,traumatic brain injury ,Brain Injuries ,Genetic Associations In Neurotrauma (GAIN) Consortium ,Public Health and Health Services ,Human medicine ,Transcriptome ,Genome-Wide association study - Abstract
EBioMedicine 77, 103933 (2022). doi:10.1016/j.ebiom.2022.103933, Published by Elsevier, Amsterdam [u.a.]
- Published
- 2022
38. Life After Mild Traumatic Brain Injury: Widespread Structural Brain Changes Associated With Psychological Distress Revealed With Multimodal Magnetic Resonance Imaging
- Author
-
Francesca Sibilia, Rachel M. Custer, Andrei Irimia, Farshid Sepehrband, Arthur W. Toga, Ryan P. Cabeen, Opeolu Adeoye, Neeraj Badjatia, Yelena Bodien, M. Ross Bullock, Randall Chesnut, John D. Corrigan, Karen Crawford, Ramon Diaz-Arrastia, Ann-Christine Duhaime, Richard Ellenbogen, V. Ramana Feeser, Adam R. Ferguson, Brandon Foreman, Raquel Gardner, Etienne Gaudette, Dana Goldman, Luis Gonzalez, Shankar Gopinath, Rao Gullapalli, J. Claude Hemphill, Gillian Hotz, Frederick K. Korley, Joel Kramer, Natalie Kreitzer, Chris Lindsell, Joan Machamer, Christopher Madden, Alastair Martin, Thomas McAllister, Randall Merchant, Laura B. Ngwenya, Florence Noel, David Okonkwo, Eva Palacios, Daniel Perl, Ava Puccio, Miri Rabinowitz, Claudia Robertson, Jonathan Rosand, Angelle Sander, Gabriella Satris, David Schnyer, Seth Seabury, Sabrina Taylor, Arthur Toga, Alex Valadka, Mary Vassar, Paul Vespa, Kevin Wang, John K. Yue, and Ross Zafonte
- Subjects
General Medicine - Published
- 2022
39. Cerebrovascular complications of coccidioidomycosis meningitis: Case report and systematic review
- Author
-
Matthew J. Barkovich, Taemin Oh, Anthony T. Lee, John K. Yue, Kunal P. Raygor, Ethan A. Winkler, Alex Y. Lu, Ryan R L Phelps, and Harry Hollander
- Subjects
medicine.medical_specialty ,Percutaneous ,03 medical and health sciences ,0302 clinical medicine ,Aneurysm ,Physiology (medical) ,Medicine ,cardiovascular diseases ,Dexamethasone ,business.industry ,Mortality rate ,Meninges ,Vasospasm ,General Medicine ,medicine.disease ,Surgery ,Coccidioidomycosis meningitis ,medicine.anatomical_structure ,Neurology ,030220 oncology & carcinogenesis ,cardiovascular system ,Neurology (clinical) ,business ,030217 neurology & neurosurgery ,Fluconazole ,medicine.drug - Abstract
Coccidioidomycosis exposure is common in the southwest United States and northern Mexico. Dissemination to the meninges is the most severe form of progression. Although ischemic strokes are well-reported in these patients, other cerebrovascular complications of coccidioidomycosis meningitis (CM), as well as their treatment options and outcomes, have not been systematically studied. We present a uniquely severe case of CM with several cerebrovascular complications. We also systematically queried PubMed and EMBASE databases, including articles published before April 2020 reporting human patients with CM-induced cerebrovascular pathology other than ischemic infarcts. Sixteen articles met inclusion criteria, which describe 6 patients with aneurysmal hemorrhage, 10 with non-aneurysmal hemorrhage, one with vasospasm, and one with transient ischemic attacks. CM-associated aneurysms invariably presented with hemorrhage. These were universally fatal until the past decade, when advances in surgical clipping and/or combined surgical and endovascular treatment have improved outcomes. We found that non-aneurysmal intracranial hemorrhages were limited to male patients, involved a diverse set of intracranial vasculature, and had a mortality rate surpassing 80%. Vasospasm was reported once, and was treated with percutaneous transluminal angioplasty. Transient ischemic attacks were reported once, and were successfully treated with fluconazole and dexamethasone. This review suggests that CM can present with a wide array of cerebrovascular complications, including ischemic infarcts, aneurysmogenesis, non-aneurysmal intracranial hemorrhage, vasospasm, and transient ischemic attacks. Mortality has improved over time due to advances in surgical and endovascular treatment modalities. The exception is non-aneurysmal intracranial hemorrhage, which remains associated with high mortality rates and few targeted therapeutic options.
- Published
- 2020
40. Employing p+58Ni elastic scattering for determination of K-shell ionization cross section of 58Ni19+ in collisions with hydrogen gas target at 95 MeV/u
- Author
-
Meng Wang, Caojie Shao, Peng-Xiong Ma, Zhang Jipeng, Yu. A. Litvinov, K. Yue, Y. Wang, V.P. Shevelko, I. Yu. Tolstikhina, Y.Y. Yang, B. Mei, Y. H. Zhang, Xiao-Lin Tu, Xiaojuan Zhou, Zheng-Hang Sun, and X. C. Chen
- Subjects
Elastic scattering ,Physics ,Nuclear and High Energy Physics ,Hydrogen ,Proton ,010308 nuclear & particles physics ,Nuclear Theory ,Electron shell ,chemistry.chemical_element ,01 natural sciences ,Ion ,Cross section (physics) ,chemistry ,Ionization ,0103 physical sciences ,Physics::Atomic and Molecular Clusters ,Physics::Atomic Physics ,Atomic physics ,010306 general physics ,Instrumentation ,Storage ring - Abstract
We present a new experimental method for measuring inner-shell ionization cross sections of low-charged ions colliding with hydrogen gas target in a storage ring. The method is based on a calibration by the well-known differential cross sections of proton elastic scattering on nuclei. K-shell ionization cross section of 1047(100) barn for the 95 MeV/u 58Ni19+ ions colliding with hydrogen atoms was obtained in this work. Compared to the measured ionization cross section, a good agreement is achieved with the prediction by the Relativistic Ionization CODE Modified program (RICODE-M).
- Published
- 2020
41. Polytrauma Is Associated with Increased Three- and Six-Month Disability after Traumatic Brain Injury: A TRACK-TBI Pilot Study
- Author
-
John K. Yue, Hester F. Lingsma, Cecilia L Dalle Ore, J. Russell Huie, David M. Schnyer, Esther L. Yuh, Amy J Markowitz, Alex B. Valadka, David O. Okonkwo, Gabriela G. Satris, Mary J. Vassar, Young M Lee, Ava M. Puccio, Sabrina R Taylor, Ethan A. Winkler, Pratik Mukherjee, Adam R. Ferguson, Hansen Deng, and Geoffrey T. Manley
- Subjects
medicine.medical_specialty ,Traumatic brain injury ,Logistic regression ,Clinical knowledge ,functional outcome ,Injury - Trauma - (Head and Spine) ,Clinical Research ,Internal medicine ,Medicine ,polytrauma ,outcome measure ,business.industry ,traumatic brain injury ,Trauma center ,Rehabilitation ,Glasgow Coma Scale ,Neurosciences ,lcsh:Medical emergencies. Critical care. Intensive care. First aid ,Odds ratio ,Injuries and accidents ,lcsh:RC86-88.9 ,medicine.disease ,Polytrauma ,Confidence interval ,Brain Disorders ,disability ,Injury (total) Accidents/Adverse Effects ,Original Article ,business ,Injury - Traumatic brain injury - Abstract
Polytrauma and traumatic brain injury (TBI) frequently co-occur and outcomes are routinely measured by the Glasgow Outcome Scale-Extended (GOSE). Polytrauma may confound GOSE measurement of TBI-specific outcomes. Adult patients with TBI from the prospective Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot (TRACK-TBI Pilot) study had presented to a Level 1 trauma center after injury, received head computed tomography (CT) within 24 h, and completed the GOSE at 3 months and 6 months post-injury. Polytrauma was defined as an Abbreviated Injury Score (AIS) ≥3 in any extracranial region. Univariate regressions were performed using known GOSE clinical cutoffs. Multi-variable regressions were performed for the 3- and 6-month GOSE, controlling for known demographic and injury predictors. Of 361 subjects (age 44.9 ± 18.9 years, 69.8% male), 69 (19.1%) suffered polytrauma. By Glasgow Coma Scale (GCS) assessment, 80.1% had mild, 5.8% moderate, and 14.1% severe TBI. On univariate logistic regression, polytrauma was associated with increased odds of moderate disability or worse (GOSE ≤6; 3 month odds ratio [OR] = 2.57 [95% confidence interval (CI): 1.50-4.41; 6 month OR = 1.70 [95% CI: 1.01-2.88]) and death/severe disability (GOSE ≤4; 3 month OR = 3.80 [95% CI: 2.03-7.11]; 6 month OR = 3.33 [95% CI: 1.71-6.46]). Compared with patients with isolated TBI, more polytrauma patients experienced a decline in GOSE from 3 to 6 months (37.7 vs. 24.7%), and fewer improved (11.6 vs. 22.6%). Polytrauma was associated with greater univariate ordinal odds for poorer GOSE (3 month OR = 2.79 [95% CI: 1.73-4.49]; 6 month OR = 1.73 [95% CI: 1.07-2.79]), which was conserved on multi-variable ordinal regression (3 month OR = 3.05 [95% CI: 1.76-5.26]; 6 month OR = 2.04 [95% CI: 1.18-3.42]). Patients with TBI with polytrauma are at greater risk for 3- and 6-month disability compared with those with isolated TBI. Methodological improvements in assessing TBI-specific disability, versus disability attributable to all systemic injuries, will generate better TBI outcomes assessment tools.
- Published
- 2020
42. Trends in safety and cost of deep brain stimulation for treatment of movement disorders in the United States: 2002–2014
- Author
-
John K. Yue, Doris D. Wang, and Hansen Deng
- Subjects
Adult ,medicine.medical_specialty ,Movement disorders ,Deep brain stimulation ,Parkinson's disease ,Deep Brain Stimulation ,Essential Tremor ,medicine.medical_treatment ,Disease ,03 medical and health sciences ,0302 clinical medicine ,Physical medicine and rehabilitation ,medicine ,Humans ,Dystonia ,Essential tremor ,business.industry ,Parkinson Disease ,General Medicine ,Hospital cost ,medicine.disease ,United States ,nervous system diseases ,Hospitalization ,030220 oncology & carcinogenesis ,Surgery ,Neurology (clinical) ,medicine.symptom ,business ,030217 neurology & neurosurgery - Abstract
Deep brain stimulation (DBS) is being increasingly utilized to treat movement disorders including Parkinson's disease (PD), essential tremor (ET), and dystonia. An improved understanding of national trends in safety and cost is necessary. Herein, our objectives are to (1) characterize complication, mortality, and cost profiles of patients undergoing DBS for movement disorders in the United States, (2) identify predictors of morbidity and mortality, and (3) evaluate impact of complications on cost.DBS surgeries were extracted from the National Inpatient Sample (NIS) 2002-2014 for the clinical indications of PD, ET, and dystonia. Patient characteristics and eight complication categories (hardware malfunction, infection, neurological, other haemorrhagic, thromboembolic, cardiac, pulmonary, and renal/urinary) were reviewed. Outcomes included complications, mortality, hospitalization length, and inflation-adjusted cost.There were 44,866 weighted admissions (PD-73.5%, ET-22.7%, dystonia-3.8%). The number of procedures increased 2.22-fold from 2002 to 2014 (Increased DBS utilization for adult movement disorders in the United States from 2002 to 2014 was attributed to rapid adoption by teaching hospitals for PD. DBS remains a safe procedure with low overall complications and stable inpatient costs from 2002 to 2014. Complication risks vary by type of movement disorder, and although rare, multiple complications increase morbidity and cost of care.
- Published
- 2020
43. Numerical analysis of the effect of external opening on fire safety of refuge floors in tall buildings
- Author
-
T. K. Yue, K. W. Lau, and Wan Ki Chow
- Subjects
021110 strategic, defence & security studies ,Numerical analysis ,0211 other engineering and technologies ,Public Health, Environmental and Occupational Health ,Forensic engineering ,Environmental science ,Natural ventilation ,021108 energy ,02 engineering and technology ,Fire safety - Abstract
Refuge floors are fire safety requirements for tall buildings in many Asia-Oceania cities. However, there are concerns on the adequate provision of cross-ventilation and drencher system to openings on refuge floors. To review the existing situation, a survey of 44 building developments involving 51 blocks of both residential and non-residential tall buildings was conducted. A new fire safety parameter, i.e. the ratio of external wall openings areas to the nominal total wall areas of refuge floors (wall opening area ratio, or WOAR), was introduced to provide a quantitative measure in analysing fire safety level of tall buildings. To study how the ventilation provision is affected by WOAR, numerical simulations for the effect of natural ventilation on fire growth on the refuge floor were conducted by incorporating the wind data collected from the tallest building in Hong Kong. In the simulations, an office layout was adopted on both upper and lower floors for the sake of illustrating the possible smoke and heat spread from lower floor to upper floor (refuge floor). Finally, fire safety issues in relation to natural ventilation on fire in tall buildings were discussed. Suggestions in improving the fire safety design of tall buildings are proposed.
- Published
- 2020
44. The Path to U.S. Neurosurgical Residency for Foreign Medical Graduates: Trends from a Decade 2007–2017
- Author
-
Shannon Lu, John K. Yue, Michael G. Brandel, Ankush Chandra, Neil D. Almeida, Harsh Wadhwa, Mitchel S. Berger, Akshar Patel, Michael W. McDermott, Mohammed Nuru, Walid Ibn Essayed, Manish K. Aghi, and Justin Cheng
- Subjects
Retrospective review ,medicine.medical_specialty ,business.industry ,Neurosurgery ,Internship and Residency ,United States ,03 medical and health sciences ,0302 clinical medicine ,Education, Medical, Graduate ,Medical graduate ,030220 oncology & carcinogenesis ,Family medicine ,Humans ,Medicine ,Surgery ,Neurology (clinical) ,Foreign Medical Graduates ,business ,030217 neurology & neurosurgery - Abstract
The increasing competitiveness of the neurosurgical residency match has made it progressively difficult for foreign medical graduates (FMGs) to match in neurosurgery. We compared FMG to U.S. medical graduate (USMG) match rates in neurosurgery and identified factors associated with match outcomes for FMGs in neurosurgery.Retrospective review of American Association of Neurological Surgeons membership data and Association of American Medical Colleges Charting the Outcomes match reports (2007-2017).Across 1857 neurosurgical residents (USMG: 91.1%, FMG: 8.9%), average FMG match rates were 24% (range, 15%-35%) versus 83% (range, 75%-94%; P0.001) for USMG. FMGs were more male (89.5% vs. 82.0%, P = 0.016), older (33.9 vs. 31.8 years, P = 0.008), and more likely to take research year(s) before matching (95.8% vs. 78.5%, P0.001). FMGs had greater publications (5 vs. 2, P0.001) and H-indices (3 vs. 1, P0.001). The number of matched USMGs increased by 3.3 annually, whereas that of matched FMGs remained unchanged (β = 0.07). Compared with USMGs, FMGs were less likely to match to National Institutes of Health (NIH) Top 40 (32.7% vs. 47.5%, P0.001) and Doximity Top 20 (20.0% vs. 29.0%, P = 0.014) programs. FMGs with prior U.S. neurosurgery program affiliation were more likely to match at NIH and Doximity Top 20 programs (P0.05). For NIH programs, FMGs were older (35.3 vs. 32.0, P = 0.011), had higher H-indices (5 vs. 2, P0.001), publications (7 vs. 2, P0.001), and were more likely to take research year(s) (94.4% vs. 76.0%, P = 0.002) than USMGs. FMGs had similar patterns for matching into Doximity Top 20 programs.Although FMGs have lower match rates into U.S. neurosurgery residencies than USMGs, several demographic, professional, and academic factors could increase the chances of successful FMG neurosurgical match.
- Published
- 2020
45. Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles
- Author
-
Hoi Cheong Siu, April S. Chan, Anthony K W Chan, Jason W. H. Wong, Alice H Y Man, Wai Yin Tsui, Annie S Y Chan, Ho Sang Hui, Bernard C H Lee, Hans Clevers, D Chan, Arthur Kwok Leung Cheung, Siu Lun Ho, Helen H.N. Yan, Sarah S K Yue, Oswens Siu-Hung Lo, Yang Gao, Suet Yi Leung, Wai Lun Law, Siu Tsan Yuen, and Hubrecht Institute for Developmental Biology and Stem Cell Research
- Subjects
Ubiquitin-Protein Ligases ,Adenomatous Polyposis Coli Protein ,Mutant ,Bone Morphogenetic Protein 2 ,Tissue Banks ,Biology ,Transcriptome ,Exome Sequencing ,Organoid ,Humans ,CRISPR ,Exome ,Bone Morphogenetic Protein Receptors, Type I ,Smad4 Protein ,Models, Genetic ,Gene Expression Profiling ,Receptor-Like Protein Tyrosine Phosphatases, Class 2 ,Gastroenterology ,Wnt signaling pathway ,Receptor Protein-Tyrosine Kinases ,Genetic Profile ,Phenotype ,BMPR1A ,Up-Regulation ,Organoids ,Mutation ,Cancer research ,CRISPR-Cas Systems ,Gene Fusion ,Colorectal Neoplasms ,Thrombospondins ,Cell Adhesion Molecules - Abstract
ObjectiveSporadic early-onset colorectal cancer (EOCRC) has bad prognosis, yet is poorly represented by cell line models. We examine the key mutational and transcriptomic alterations in an organoid biobank enriched in EOCRCs.DesignWe established paired cancer (n=32) and normal organoids (n=18) from 20 patients enriched in microsatellite-stable EOCRC. Exome and transcriptome analysis was performed.ResultsWe observed a striking diversity of molecular phenotypes, including PTPRK-RSPO3 fusions. Transcriptionally, RSPO fusion organoids resembled normal colon organoids and were distinct from APC mutant organoids, with high BMP2 and low PTK7 expression. Single cell transcriptome analysis confirmed the similarity between RSPO fusion organoids and normal organoids, with a propensity for maturation on Wnt withdrawal, whereas the APC mutant organoids were locked in progenitor stages. CRISPR/Cas9 engineered mutation of APC in normal human colon organoids led to upregulation of PTK7 protein and suppression of BMP2, but less so with an engineered RNF43 mutation. The frequent co-occurrence of RSPO fusions with SMAD4 or BMPR1A mutation was confirmed in TCGA database searches. RNF43 mutation was found in organoid from a leukaemia survivor with a novel mutational signature; and organoids with POLE proofreading mutation displayed ultramutation. The cancer organoid genomes were stable over long culture periods, while normal human colon organoids tended to be subject to clonal dominance over time.ConclusionsThese organoid models enriched in EOCRCs with linked genomic data fill a gap in existing CRC models and reveal distinct genetic profiles and novel pathway cooperativity.
- Published
- 2020
46. Young‐onset type 2 diabetes and younger current age: increased susceptibility to retinopathy in contrast to other complications
- Author
-
Stephen M. Twigg, Maria I. Constantino, Jencia Wong, Timothy Middleton, Sophia Zoungas, Ted Wu, Mario D'Souza, Dennis K. Yue, and Lynda Molyneaux
- Subjects
Adult ,Male ,Pediatrics ,medicine.medical_specialty ,Complications ,Endocrinology, Diabetes and Metabolism ,Population ,Myocardial Ischemia ,030209 endocrinology & metabolism ,Type 2 diabetes ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Diabetes mellitus ,Internal Medicine ,medicine ,Albuminuria ,Humans ,Research: Complications ,Diabetic Nephropathies ,030212 general & internal medicine ,Age of Onset ,Renal Insufficiency, Chronic ,education ,Research Articles ,Aged ,Macrovascular disease ,Peripheral Vascular Diseases ,education.field_of_study ,Diabetic Retinopathy ,business.industry ,Age Factors ,Odds ratio ,Middle Aged ,medicine.disease ,Cerebrovascular Disorders ,Peripheral neuropathy ,Diabetes Mellitus, Type 2 ,Female ,Disease Susceptibility ,medicine.symptom ,business ,Diabetic Angiopathies ,Retinopathy - Abstract
Background Type 2 diabetes diagnosed during youth and early adulthood is aggressive and associated with a high burden of vascular complications. The increase in complications is often attributed to long disease duration and poor metabolic control. Whether people with young‐onset type 2 diabetes are inherently more susceptible to long‐term complications than those diagnosed in later adulthood is unclear. Methods Prospective data from 3322 individuals, diagnosed between the age of 15 and 70 years and collected 10–25 years after diabetes diagnosis, were analysed. The cross‐sectional associations between age at diagnosis and microvascular and macrovascular complications were analysed using logistic regression models, adjusted for duration of diabetes exposure and metabolic risk factors including blood pressure, cholesterol and updated mean HbA1c. Results The prevalence of retinopathy was highest in those with young‐onset type 2 diabetes (diagnosed at age 15 to, What's new? Young‐onset type 2 diabetes is an aggressive disease, associated with a higher burden of complications than that seen in older‐onset diabetes.It is not known whether young people have an underlying increased susceptibility to complications or whether their long‐term excess risk of complications can be explained by glycaemia and longer duration of disease exposure.Unlike other complications, risk of retinopathy in young‐onset type 2 diabetes (or those with a younger current age) is twofold higher than in older‐onset type 2 diabetes, after adjustment for duration of diabetes exposure, glycaemia and other known risk factors. This finding supports an underlying increased susceptibility to retinal complications for young people.This increased risk of retinopathy indicates a need for more frequent surveillance and aggressive management of known risk factors, and supports a reconsideration of the diabetic retinopathy guidelines for young people and those with a younger age at diagnosis.A search for as yet unidentified contributing factors for retinopathy risk in young people is warranted.
- Published
- 2020
47. Risk factors for deep surgical site infection following thoracolumbar spinal surgery
- Author
-
Amy Nichols, Praveen V. Mummaneni, John K. Yue, Caleb S. Edwards, Aaron J. Clark, Sanjay S. Dhall, Dean Chou, Catherine Liu, Hansen Deng, Simon G Ammanuel, Henry C. Skrehot, Taemin Oh, Andrew K Chan, Christopher P. Ames, Alvin Y. Chan, and Sravani Kondapavulur
- Subjects
medicine.medical_specialty ,business.industry ,General Medicine ,Odds ratio ,medicine.disease ,Logistic regression ,Confidence interval ,Surgery ,Coronary artery disease ,Surgical pathology ,03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Diabetes mellitus ,medicine ,Neurosurgery ,Complication ,business ,030217 neurology & neurosurgery - Abstract
OBJECTIVE Surgical site infection (SSI) following spine surgery causes major morbidity and greatly impedes functional recovery. In the modern era of advanced operative techniques and improved perioperative care, SSI remains a problematic complication that may be reduced with institutional practices. The objectives of this study were to 1) characterize the SSI rate and microbial etiology following spine surgery for various thoracolumbar diseases, and 2) identify risk factors that were associated with SSI despite current perioperative management. METHODS All patients treated with thoracic or lumbar spine operations on the neurosurgery service at the University of California, San Francisco from April 2012 to April 2016 were formally reviewed for SSI using the National Healthcare Safety Network (NHSN) guidelines. Preoperative risk variables included age, sex, BMI, smoking, diabetes mellitus (DM), coronary artery disease (CAD), ambulatory status, history of malignancy, use of preoperative chlorhexidine gluconate (CHG) showers, and the American Society of Anesthesiologists (ASA) classification. Operative variables included surgical pathology, resident involvement, spine level and surgical technique, instrumentation, antibiotic and steroid use, estimated blood loss (EBL), and operative time. Multivariable logistic regression was used to evaluate predictors for SSI. Odds ratios and 95% confidence intervals were reported. RESULTS In total, 2252 consecutive patients underwent thoracolumbar spine surgery. The mean patient age was 58.6 ± 13.8 years and 49.6% were male. The mean hospital length of stay was 6.6 ± 7.4 days. Sixty percent of patients had degenerative conditions, and 51.9% underwent fusions. Sixty percent of patients utilized presurgery CHG showers. The mean operative duration was 3.7 ± 2 hours, and the mean EBL was 467 ± 829 ml. Compared to nonfusion patients, fusion patients were older (mean 60.1 ± 12.7 vs 57.1 ± 14.7 years, p II (48.0% vs 36.0%, p < 0.001), and experienced longer operative times (252.3 ± 120.9 minutes vs 191.1 ± 110.2 minutes, p < 0.001). Eleven patients had deep SSI (0.49%), and the most common causative organisms were methicillin-sensitive Staphylococcus aureus and methicillin-resistant S. aureus. Patients with CAD (p = 0.003) or DM (p = 0.050), and those who were male (p = 0.006), were predictors of increased odds of SSI, and presurgery CHG showers (p = 0.001) were associated with decreased odds of SSI. CONCLUSIONS This institutional experience over a 4-year period revealed that the overall rate of SSI by the NHSN criteria was low at 0.49% following thoracolumbar surgery. This was attributable to the implementation of presurgery optimization, and intraoperative and postoperative measures to prevent SSI across the authors’ institution. Despite prevention measures, having a history of CAD or DM, and being male, were risk factors associated with increased SSI, and presurgery CHG shower utilization decreased SSI risk in patients. ABBREVIATIONS ASA = American Society of Anesthesiologists; CAD = coronary artery disease; CHG = chlorhexidine gluconate; CI = confidence interval; DM = diabetes mellitus; EBL = estimated blood loss; LOS = length of stay; MIS = minimally invasive surgery; MRSA = methicillin-resistant Staphylococcus aureus; MRSE = methicillin-resistant Staphylococcus epidermidis; MSSA = methicillin-sensitive S. aureus; MSSE = methicillin-sensitive S. epidermidis; NHSN = National Healthcare Safety Network; OR = odds ratio; SSI = surgical site infection.
- Published
- 2020
48. Administration study of recombinant human relaxin‐2 in horse for doping control purpose
- Author
-
April S.Y. Wong, Emmie N.M. Ho, Gary N. W. Leung, Terence S.M. Wan, Wai Him Kwok, Samuel K. Yue, and Timmy L.S. Choi
- Subjects
Male ,Pharmaceutical Science ,Vasodilation ,Endogeny ,Urine ,Peptide hormone ,Pharmacology ,01 natural sciences ,Analytical Chemistry ,03 medical and health sciences ,0302 clinical medicine ,Limit of Detection ,Tandem Mass Spectrometry ,medicine ,Animals ,Humans ,Environmental Chemistry ,Horses ,030216 legal & forensic medicine ,Spectroscopy ,Doping in Sports ,Relaxin ,Pregnancy ,Recombinant human relaxin ,business.industry ,010401 analytical chemistry ,Horse ,medicine.disease ,0104 chemical sciences ,business ,Chromatography, Liquid - Abstract
The insulin-like peptide relaxin (RLX), an endogenous peptide hormone produced in human for pregnancy and reproduction, is also known to exert a range of physiological and pathological effects. Its use is banned in human sports, horseracing, and equestrian competitions due to its potential performance enhancing effect through vasodilation resulting in the increase of blood and oxygen supplies to muscles. Little is known about the biotransformation and elimination of RLX in horses. This paper describes an administration study of rhRLX-2 and its elimination in horses, and the development of sensitive methods for the detection and confirmation of rhRLX-2 in both horse plasma and urine by nano-liquid chromatography/high resolution mass spectrometry (nano-LC/HRMS) after immunoaffinity extraction with the objective of controlling the abuse of rhRLX-2 in horses. The limits of detection in plasma and urine are 2 pg/mL and 5 pg/mL, respectively. Two thoroughbred geldings were each administered one dose of 10 mg rhRLX-2 subcutaneously daily for 3 consecutive days. The rhRLX-2 could be detected and confirmed in the plasma and urine samples collected 105 h and 80 h, respectively, after the last dose of administration. For doping control purposes, rhRLX-2 ELISA could be used as a screening test to identify potential positive samples for further investigation using the nano-LC/HRMS methods.
- Published
- 2020
49. Clinical Implementation of Novel Spinal Cord Perfusion Pressure Protocol in Acute Traumatic Spinal Cord Injury at U.S. Level I Trauma Center: TRACK-SCI Study
- Author
-
Ethan A. Winkler, William D. Whetstone, Leigh H. Thomas, Xuan Duong Fernandez, John K. Yue, Jason F. Talbott, Sanjay S. Dhall, Debra D. Hemmerle, Praveen V. Mummaneni, Vineeta Singh, Jonathan Z. Pan, Michael S. Beattie, Nikolaos Kyritsis, Lisa U. Pascual, J. Russell Huie, Adam R. Ferguson, Jacqueline C. Bresnahan, Philip Weinstein, and Geoffrey T. Manley
- Subjects
Mean arterial pressure ,Traumatic spinal cord injury ,Thoracic Vertebrae ,03 medical and health sciences ,Surgical decompression ,0302 clinical medicine ,Blunt ,Clinical Protocols ,Trauma Centers ,Cerebrospinal Fluid Pressure ,Ischemia ,medicine ,Humans ,Vasoconstrictor Agents ,Infusions, Intravenous ,Spinal cord injury ,Spinal Cord Injuries ,Aged ,business.industry ,Trauma center ,Laminectomy ,Standard of Care ,Middle Aged ,Decompression, Surgical ,Spinal cord ,medicine.disease ,Combined Modality Therapy ,Treatment Outcome ,medicine.anatomical_structure ,Spinal Cord ,030220 oncology & carcinogenesis ,Anesthesia ,Cervical Vertebrae ,Drainage ,Fluid Therapy ,Surgery ,Neurology (clinical) ,business ,Perfusion ,030217 neurology & neurosurgery - Abstract
We sought to report the safety of implementation of a novel standard of care protocol using spinal cord perfusion pressure (SCPP) maintenance for managing traumatic spinal cord injury (SCI) in lieu of mean arterial pressure goals at a U.S. Level I trauma center.Starting in December 2017, blunt SCI patients presenting24 hours after injury with admission American Spinal Injury Association Impairment Scale (AIS) A-C (or AIS D at neurosurgeon discretion) received lumbar subarachnoid drain (LSAD) placement for SCPP monitoring in the intensive care unit and were included in the TRACK-SCI (Transforming Research and Clinical Knowledge in Spinal Cord Injury) data registry. This SCPP protocol comprises standard care at our institution. SCPPs were monitored for 5 days (goal ≥65 mm Hg) achieved through intravenous fluids and vasopressor support. AISs were assessed at admission and day 7.Fifteen patients enrolled to date were aged 60.5 ± 17 years. Injury levels were 93.3% (cervical) and 6.7% (thoracic). Admission AIS was 20.0%/20.0%/26.7%/33.3% for A/B/C/D. All patients maintained mean SCPP ≥65 mm Hg during monitoring. Fourteen of 15 cases required surgical decompression and stabilization with time to surgery 8.8 ± 7.1 hours (71.4%12 hours). At day 7, 33.3% overall and 50% of initial AIS A-C had an improved AIS. Length of stay was 14.7 ± 8.3 days. None had LSAD-related complications. There were 7 respiratory complications. One patient expired after transfer to comfort care.In our initial experience of 15 patients with acute SCI, standardized SCPP goal-directed care based on LSAD monitoring for 5 days was feasible. There were no SCPP-related complications. This is the first report of SCPP implementation as clinical standard of care in acute SCI.
- Published
- 2020
50. Concussion and Mild-Traumatic Brain Injury in Rural Settings: Epidemiology and Specific Health Care Considerations
- Author
-
Catherine G Suen, Ryan R L Phelps, Lauro N. Avalos, Tene A. Cage, Pavan S. Upadhyayula, and John K. Yue
- Subjects
medicine.medical_specialty ,Telemedicine ,Poison control ,Review Article ,Suicide prevention ,Occupational safety and health ,030218 nuclear medicine & medical imaging ,lcsh:RC321-571 ,03 medical and health sciences ,0302 clinical medicine ,prevention ,return to play ,Health care ,Injury prevention ,Concussion ,medicine ,lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry ,business.industry ,mild-traumatic brain injury ,General Neuroscience ,medicine.disease ,Triage ,Emergency medicine ,concussion ,epidemiology ,Neurology (clinical) ,rural ,business ,health disparity ,030217 neurology & neurosurgery - Abstract
Background Mild-traumatic brain injury (mTBI) and concussions cause significant morbidity. To date, synthesis of specific health care disparities and gaps in care for rural mTBI/concussion patients remains needed. Methods A comprehensive literature search was performed using PubMed database for English articles with keywords “rural” and (“concussion” or “mild traumatic brain injury”) from 1991 to 2019. Eighteen articles focusing on rural epidemiology (n = 5), management/cost (n = 5), military (n = 2), and concussion prevention/return to play (n = 6) were included. Results mTBI/concussion incidence was higher in rural compared with urban areas. Compared with urban patients, rural patients were at increased risk for vehicular injuries, lifetime number of concussions, admissions for observation without neuroimaging, and injury-related costs. Rural patients were less likely to utilize ambulatory and mental health services following mTBI/concussion. Rural secondary schools had decreased access to certified personnel for concussion evaluation, and decreased use of standardized assessment instruments/neurocognitive testing. While school coaches were aware of return-to-play laws, mTBI/concussion education rates for athletes and parents were suboptimal in both settings. Rural veterans were at increased risk for postconcussive symptoms and posttraumatic stress. Telemedicine in rural/low-resource areas is an emerging tool for rapid evaluation, triage, and follow-up. Conclusions Rural patients are at unique risk for mTBI/concussions and health care costs. Barriers to care include lower socioeconomic status, longer distances to regional medical center, and decreased availability of neuroimaging and consultants. Due to socioeconomic and distance barriers, rural schools are less able to recruit personnel certified for concussion evaluation. Telemedicine is an emerging tool for remote triage and evaluation.
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.